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DUDE, WHERE’S MY PATENT?:  ILLEGALITY, 
MORALITY, AND THE PATENTABILITY OF 
MARIJUANA 
“[A] country without a patent office and good patent laws [is] 
just a crab, and [cannot] travel any way but sideways or 
backways.”–Mark Twain 
I.  INTRODUCTION 
Ben Holmes is a “cannabis seed geek.”1  After leaving a securities 
analyst position at Merrill Lynch, Holmes became a self-taught scientist, 
engineer, and botanist dedicated to developing high-quality cannabis 
seeds.2  Holmes’ most prized invention is the Otto II, a medical-grade 
marijuana strain.3  In January 2015, Holmes filed a plant patent application 
to protect his Otto II strain and, if awarded, Holmes’s patent covering the 
Otto II would be the first plant patent issued protecting a cannabis strain.4 
As the marijuana industry continues to grow rapidly, marijuana 
entrepreneurs are concerned large companies seeking to capitalize on 
marijuana will enter the industry, steal their intellectual property, and 
take away their market.5  Accordingly, as states legalize marijuana for 
                                                
1 Jason Blevins, Pot Growers Cultivating in the Shadows Seek U.S. Patent Protection, DENVER 
POST (Dec. 19, 2014), http://www.denverpost.com/2014/12/19/pot-growers-cultivating-
in-the-shadows-seek-u-s-patent-protection/ [https://perma.cc/HB37-DFNG].  Most 
recently, the United States Patent and Trademark Office (“USPTO”) issued the “first-ever 
patent for a plant containing significant amounts of THC[.]”  Greg Walters, What a Looming 
Patent War Could Mean for the Future of the Marijuana Industry, VICE NEWS (Apr. 20, 2016), 
https://news.vice.com/article/a-patent-for-cannabis-plants-is-already-a-reality-and-more-
are-expected-to-follow [https://perma.cc/C6HK-MRBP].  Cannabidiol (“CBD”) is 
marijuana’s major non-psychoactive ingredient, while tetrahydrocannabinol (“THC”) is the 
plant’s psychoactive compound.  Id.  CBD has been credited with having antipsychotic 
effects.  Id. U.S. Pat. No. 9,095,554 (“’554 Patent”), which was issued August 4, 2015, “relates 
to specialty cannabis plants, compositions and methods for making and using said cannabis 
plants and compositions derived thereof.”  U.S. Pat. No. 9,095,554 (Mar. 17, 2014).  The ’554 
Patent is a utility patent, whereas the patent Ben Holmes seeks is a plant patent.  Id. 
2 See Blevins, supra note 1 (telling the story of Ben Holmes, a “self-taught scientist, 
engineer, farmer[,] and cannabis seed geek” who is applying to obtain the first patent 
protecting a marijuana strain). 
3 See id. (indicating Holmes’s Otto II is a “high-CBD, low-THC strain” that could “fuel 
medical therapies”).   
4 Id. 
5 See Matt Ferner, Legal Marijuana Is the Fastest-Growing Industry in the U.S.:  Report, 
HUFFINGTON POST (Jan. 26, 2015), http://www.huffingtonpost.com/2015/01/26/ 
marijuana-industry-fastest-growing_n_6540166.html [https://perma.cc/S99X-EQ7Z] 
(“[L]egal marijuana is the fastest-growing industry in the [United States] . . . .”).  In fact, the 
marijuana industry was a $2.7 billion market in 2014, growing 74 percent from 2013.  Id.  If 
the trend towards legalization continues, it could become more lucrative than the National 
Football League (“NFL”) industry by 2020.  Christopher Ingraham, The Marijuana Industry 
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medical or recreational use, marijuana entrepreneurs become increasingly 
interested in seeking intellectual property protection.6  Specifically, 
entrepreneurs are interested in patent protection.7  However, marijuana 
remains illegal under federal law, and because patent law is established 
under federal law, attorneys do not know whether the United States 
                                                
Could Be Bigger Than the NFL by 2020, WASH. POST (Oct. 24, 2014), 
http://www.washingtonpost.com/news/wonkblog/wp/2014/10/24/the-marijuana-
industry-could-be-bigger-than-the-nfl-by-2020/ [https://perma.cc/VZ48-23BE].  See also 
Lisa Shuchman, Roll Another Pot Patent (For the Road), CORP. COUNSEL (Apr. 1, 2015), 
http://www.corpcounsel.com/id=1202722064373/Roll-Another-Pot-Patent-40For-the-
Road41 [https://perma.cc/9YVW-Z2Q6] (explaining marijuana entrepreneurs, such as 
Holmes, believe patenting their marijuana strain is important to prevent intellectual property 
theft and facilitate licensing); Blevins, supra note 1 (quoting Chad Ruby, the Chief Operating 
Officer (“COO”) of United Cannabis Corp., a publicly-traded corporation based in Denver, 
Colorado that has filed for draft patents on ratios of cannabinoids:  “We don’t want to waste 
a bunch of time and a bunch of money and a bunch of effort only to have someone take all 
our work . . . .”).  Holmes, who has experience in the financial sector, explained if intellectual 
property protection is available, large companies, once a “big cannabis industry develops,” 
will not be able to abuse the small breeders and producers and instead will “buy up the little 
ones.”  Shuchman, supra note 5.  Large pharmaceutical companies have already shown an 
interest in the marijuana industry’s potential.  Id.  For example, GW Pharma Ltd., a U.K.-
based pharmaceutical company, is “one of the most active seekers of patents for cannabis 
plants, extracts or formulations . . . .”  Id.  Tobacco companies are also expected to become 
interested in the marijuana industry because they “already have the infrastructure needed 
to grow marijuana plants” on a large scale.  Id.  Furthermore, according to industry watchers, 
companies like Monsanto, Altria Group, Pfizer, Walgreens, and Anheuser-Busch Indiana 
Beverage are expected to become interested in the marijuana market’s potential.  Blevins, 
supra note 1. 
6 See State Medical Marijuana Laws, NAT’L CONF. OF ST. LEGIS. (Oct. 16, 2015), 
http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx 
[https://perma.cc/EL7R-T5FS] (discussing state medical marijuana laws and noting twenty-
three states, the District of Columbia, and Guam have laws permitting medical marijuana 
programs); see also Chris Boyette & Jacque Wilson, It’s 2015:  Is Weed Legal in Your State?, 
CNN (Jan. 7, 2015), http://www.cnn.com/2015/01/07/us/recreational-marijuana-laws/ 
[https://perma.cc/GXB8-FVXN] (stating four states—Washington, Colorado, Alaska, and 
Oregon—and Washington D.C. have legalized recreational use of marijuana); Blevins, supra 
note 1 (quoting Ben Holmes:  “[W]ith companies forming and making larger investments, 
the desire to protect intellectual property is becoming paramount.  Bleeding-edge stuff, right 
here.”); Shuchman, supra note 5 (describing the marijuana industry’s desire to obtain 
intellectual property protection and noting it is unclear whether the USPTO will issue 
patents on pending marijuana-related applications, such as the one filed by Ben Holmes). 
7 See supra note 5 and accompanying text (highlighting the reasons marijuana 
entrepreneurs are interested in patent protection, including entrepreneurs’ concerns that 
they will not able to protect their small businesses from large companies entering the 
marijuana industry and stealing market share unless they have patent protection); see also 
Amanda Ciccatelli, Patent Protection for Marijuana Plants Is the “Holy Grail” of the Marijuana 
Industry, INSIDE COUNS. (June 17, 2016), http://www.insidecounsel.com/2016/06/17/ 
patent-protection-for-marijuana-plants-is-the-holy [https://perma.cc/SEB7-WL2A] (noting 
that obtaining a patent protecting a marijuana strain is the “holy grail” of the marijuana 
industry). 
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Patent and Trademark Office (“USPTO”) will issue patents protecting 
strains of cannabis.8  Hence, it is unclear whether Holmes will be able to 
obtain a plant patent protecting his Otto II strain.9 
This Note considers what role, if any, illegality should play in a 
determination of patentable utility by examining the patentable utility of 
marijuana strains and marijuana-related inventions.10  The Note proposes 
illegality should not affect the patentable utility of an invention because 
such a rejection would be inconsistent with the goals of the patent 
system.11  Therefore, marijuana-related inventions qualify for patent 
protection despite marijuana’s illegal status under federal law.12  First, 
Part II discusses federal and state legislation on marijuana and provides 
an overview of patent law.13  Second, Part III analyzes how marijuana’s 
                                                
8 See 21 U.S.C. § 812 (2012) (classifying marijuana as a Schedule I substance).  The 
manufacturing, distribution, dispensing, or possession of Schedule I substances is unlawful 
and subject to criminal penalties.  § 841.  See also Ryan Davis, Marijuana Patent Applications 
Face Tough Road at USPTO, LAW360 (Jan. 8, 2015), http://www.law360.com/articles/ 
609140/marijuana-patent-applications-face-tough-road-at-uspto [https://perma.cc/3MTM 
-ZHH3] (pointing out many attorneys believe the USPTO will not issue patents protecting a 
substance that is illegal under federal law).  The lawyers quoted by Law360 as expressing 
concerns regarding the patentability of marijuana strains include:  David Resnick of Nixon 
Peabody LLP, John Dragseth of Fish & Richardson PC, and Douglas Sorocco of Dunlap 
Codding.  Id.  However, other attorneys have indicated that “simply because something is 
illegal doesn’t make it ineligible for a patent and that patents on marijuana strains may be 
permissible.”  Id.  Among the lawyers quoted by Law360 as being optimistic that the USPTO 
will grant patents protecting marijuana strains are:  Robert Traver of Sheridan Ross PC, Erich 
Veitenheimer of Cooley LLP, and Jeremy Hanika and Anthony Marshall of Hanika & 
Marshall LLP.  Id.  See also Blevins, supra note 1 (quoting Chad Ruby, the COO of United 
Cannabis:  “Everyone in this industry is sitting and waiting on the federal level to see what 
they will allow.”); Shuchman, supra note 5 (quoting Douglas Berman, a professor at Ohio 
State University’s Moritz College of Law:  “No one is really sure of the law yet . . . .”); 
Amanda Ciccatelli, Planting the Seed for IP Protection of Marijuana Brands, INSIDE COUNS. (Feb. 
24, 2016), http://www.insidecounsel.com/2016/02/24/planting-the-seeds-for-ip-
protection-of-marijuana [https://perma.cc/8ZFD-WY8Q] (“The dichotomy of legalization 
at the state level and the illegality of marijuana at the federal level have created a circular 
argument: IP laws and protection are within the domain of federal law; federal law insists 
that the production, sale, and the use of marijuana are illegal and, therefore, the grant of 
federal IP protection is limited.”). 
9 See supra note 8 and accompanying text (illustrating the uncertainties surrounding the 
patentability of marijuana-related inventions). 
10 See infra Part III.C (analyzing the patentability of marijuana-related inventions and 
marijuana strains). 
11 See infra Part III.D.2 (explaining why it would be inconsistent with the goals of the 
patent system to promote innovation and disclosure if illegality were considered in 
determining an invention’s patentable utility). 
12 See infra Part IV (concluding marijuana-related inventions should not lack patentable 
utility merely because of marijuana’s classification as an illegal substance under federal law). 
13 See infra Part II (discussing the Controlled Substances Act, state legislation legalizing 
marijuana, and the Patent Act). 
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illegality under federal law affects the patentable utility of marijuana 
strains and marijuana-related inventions and recommends illegality 
should not be considered when determining patentable utility.14  Last, Part 
IV concludes marijuana strains and marijuana-related inventions would 
not lack patentable utility.15 
II.  BACKGROUND 
Patent protection is “the strongest form of intellectual property 
protection.”16  For that reason, as states legalize recreational and medical 
marijuana, marijuana entrepreneurs become increasingly interested in 
protecting their inventions under patent law.17  However, patent law is a 
matter of federal law, and marijuana remains an illegal substance under 
federal law.18  As a result, it is unclear whether the USPTO, a federal 
administrative agency, will issue patents protecting marijuana strains and 
marijuana-related inventions.19  Part II provides a background to 
marijuana laws and the patent process.20  First, Part II.A distinguishes 
federal and state marijuana legislation.21  Next, Part II.B explores pertinent 
patent law principles.22  Finally, Part II.C introduces the issues 
surrounding the patentability of marijuana based on its classification as 
an illegal substance under federal law.23 
                                                
14 See infra Part III (examining what role, if any, illegality should play in a determination 
of patentable utility). 
15 See infra Part IV (concluding marijuana-related patent applications do not lack utility 
simply based on marijuana’s federal classification as an illegal substance). 
16 Sam Kamin & Viva Moffat, Trademark Laundering, Useless Patents, and Other IP Challenges 
for the Marijuana Industry, 73 WASH. & LEE 217, 264 (2016). 
17 See supra notes 5–6 and accompanying text (outlining the reasons marijuana 
entrepreneurs are interested in obtaining patent protection). 
18 See supra note 8 and accompanying text (identifying the federal ban on marijuana and 
the establishment of federal patent law). 
19 See supra note 8 and accompanying text (discussing attorney concerns on the 
patentability of marijuana strains and marijuana-related inventions).  While some attorneys 
argue the USPTO will most likely deny patent applications on a substance deemed illegal by 
federal law, there is, however, no basis to determine how the USPTO will respond to 
marijuana plant patent applications because “there has never been a precisely analogous 
situation where a substance is legal in some states, but still technically illegal nationwide.”  
Davis, supra note 8. 
20 See infra Part II (discussing federal and state legislation criminalizing and legalizing, 
respectively, the use of marijuana in the United States, as well as basis patent law principles). 
21 See infra Part II.A (exploring federal and state marijuana legislation). 
22 See infra Part II.B (providing a brief overview of relevant patent law principles). 
23 See infra Part II.C (presenting the patentability issues surrounding marijuana strains and 
marijuana-related inventions). 
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A. Marijuana Laws in the United States 
Cannabis, more commonly known as marijuana or weed, was 
accessible and freely used by Americans before it first became federally 
regulated in the early twentieth century with the passage of the Pure Food 
and Drug Act.24  State regulation followed, and by 1931, twenty-two states 
had enacted laws outlawing or regulating marijuana.25  Nonetheless, 
marijuana remained legal under federal law until 1970, when Congress 
passed the Comprehensive Drug Abuse Prevention and Control Act 
(“CDAPCA”).26  Specifically, Title II of the CDAPCA, the Controlled 
Substances Act (“CSA”), is the “key federal drug policy” regulating 
controlled substances, including marijuana.27 
The CSA was passed by Congress and signed into law by President 
Nixon to decrease drug abuse and regulate the traffic of controlled 
substances.28  Under the CSA, drugs, substances, and chemicals used to 
                                                
24 See generally Helia Garrido Hull, Lost in the Weeds of Pot Law:  The Role of Legal Ethics in 
the Movement to Legalize Marijuana, 119 PENN ST. L. REV. 333, 336–38 (2014) (exploring the 
history of marijuana use in America); see also Stephen Siff, The Illegalization of Marijuana:  A 
Brief History, ORIGINS (May 2014), http://origins.osu.edu/article/illegalization-marijuana-
brief-history/page/0/0 [https://perma.cc/B7YY-CGEY] (providing a brief history of 
marijuana laws in the United States).  The Pure Food and Drug Act was passed in 1906 and 
required medicine companies to indicate on medicine labels whether the remedy contained 
cannabis.  Siff, supra note 24.  Then, Congress enacted the Marijuana Tax Act in 1937, 
requiring people who dealt with marijuana commercially, prescribed it, or possessed it “to 
purchase a tax stamp in order to possess marijuana legally.”  Garrido Hull, supra note 24, at 
337. 
25 See Richard J. Bonnie & Charles H. Whitebread, The Forbidden Fruit and the Tree of 
Knowledge:  An Inquiry into the Legal History of American Marijuana Prohibition, 56 VA. L. REV. 
971, 1010–20 (1970) (examining the development of marijuana state legislation).  By 1931, 
twenty-one states had restricted the sale of marijuana; “one state had prohibited its use for 
any purpose, and four states had outlawed its cultivation.”  Id. at 1010–11.  For example, in 
1914, New York prohibited marijuana, and in 1905, Utah prohibited the sale or possession of 
marijuana.  Id. at 1010. 
26 See Dana Graham, Decriminalization of Marijuana:  An Analysis of the Laws in the United 
States and the Netherlands and Suggestions for Reform, 23 LOY. L.A. INT’L & COMP. L. REV. 297, 
301 (2001) (stating the Comprehensive Drug Abuse Prevention and Control Act 
(“CDAPCA”) “consolidated federal laws addressing drug trafficking and drug abuse,” as 
well as “finalized the prohibition on drugs including marijuana . . . .”); see also Siff, supra note 
24 (noting the CDAPCA classified marijuana in the most restrictive category of drugs). 
27 See Garrido Hull, supra note 24, at 338 (discussing federal law controlling marijuana). 
28 See Robert A. Mikos, Preemption under the Controlled Substances Act, 16 J. HEALTH CARE 
L. & POL’Y 5, 10 (2013) (citing Gonzales v. Raich, 545 U.S. 1, 12 (2005)) (“Congress passed the 
CSA primarily to ‘conquer drug abuse and to control the legitimate and illegitimate traffic 
in controlled substances.’”); see generally Matthew B. Hodroff, The Controlled Substances Act:  
Time to Reevaluate Marijuana, 36 WHITTIER L. REV. 117, 117 (2014) (exploring the Controlled 
Substances Act (“CSA”) and proposing a proper reassessment of marijuana under the Act); 
Robert A. Mikos, On the Limits of Supremacy:  Medical Marijuana and the States’ Overlooked 
Power to Legalize Federal Crime, 62 VAND. L. REV. 1421, 1427–36 (2009) (providing background 
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make drugs are classified into five schedules, depending on the 
substance’s potential for abuse, accepted medical use, and safety for use.29  
Congress classified marijuana as a Schedule I substance—“the most 
dangerous class of drugs”—along with heroin, LSD, and ecstasy, among 
others.30  The decision to classify marijuana as a Schedule I substance 
reflects the finding that marijuana has a high potential for abuse, no 
currently accepted medical use, and lack of accepted safety for use.31  
Accordingly, manufacturing, distributing, dispensing, and possessing 
marijuana is prohibited under federal law and subject to criminal 
prosecution.32 
Despite efforts to the contrary, Congress refuses to reschedule 
marijuana, and the Drug Enforcement Agency (“DEA”) routinely rejects 
requests to administratively reschedule marijuana.33  Thus, it appears 
                                                
information on the CSA and state medical marijuana laws). 
29 See 21 U.S.C. § 812 (2012) (establishing the five schedules of controlled substances and 
listing the findings required for each schedule).  See generally Drug Scheduling, DRUG 
ENFORCEMENT ADMIN. (Oct. 21, 2015), http://www.dea.gov/druginfo/ds.shtml 
[https://perma.cc/36SJ-245E] (explaining drug scheduling). 
30 Drug Scheduling, supra note 29.  See also § 812(c) (instructing “any material, compound, 
mixture, or preparation, which contains any quantity of any of the following hallucinogenic 
substances . . . (10) Marihuana” is a Schedule I drug or substance). 
31 See § 812(b) (indicating a substance should not be placed in Schedule I unless the 
following findings are made with respect to the substance:  “(A) The drug or other substance 
has a high potential for abuse.  (B) The drug or other substance has no currently accepted 
medical use in treatment in the United States.  (C) There is a lack of accepted safety for use 
of the drug or other substance under medical supervision.”). 
32 See § 841 (listing the acts considered unlawful and the penalties for a violation).  Under 
§ 841 it is unlawful “for any person knowingly or intentionally (1) to manufacture distribute, 
or dispense, or possess with intent to manufacture, distribute, or dispense, a controlled 
substance; or (2) to create, distribute, or dispense, or possess with intent to distribute or 
dispense, a counterfeit substance.”  § 841(a).  The penalties for a violation vary depending 
on the substance and amount of the substance.  § 841(b). 
33 See Mikos, supra note 28, at 1434–35 (noting Congress has rejected proposals to 
reschedule marijuana and that the federal government refuses to legalize marijuana).  Under 
the CSA, the Attorney General has the power to reschedule drugs.  § 814(a).  The Attorney 
General can also delegate this authority to the Drug Enforcement Agency (“DEA”).  28 C.F.R. 
§ 0.100(b) (2012).  See also Alliance for Cannabis Therapeutics v. Drug Enforcement Admin., 
15 F.3d 1131, 1132–33 (D.C. Cir. 1997) (denying petitions to review an order issued by the 
DEA denying the rescheduling of marijuana); United States v. Pickard, 100 F. Supp. 3d 981, 
988 (E.D. Cal. 2015) (denying defendant’s motion to challenge marijuana’s status as a 
Schedule I substance); Elizabeth Roth, Light, Smoke, and Fire:  How State Law Can Provide 
Medical Marijuana Users Protection from Workplace Discrimination, 55 B.C. L. REV. 1759, 1765 
n.41 (2014) (reviewing unsuccessful efforts to reschedule marijuana).  In fact, the Obama 
Administration opposed the legalization of marijuana.  See Marijuana, OFF. OF NAT’L DRUG 
CONTROL POL’Y (Oct. 21, 2015), https://www.whitehouse.gov/ondcp/marijuana 
[https://perma.cc/U2NK-PWT4] (“The Administration steadfastly opposes legalization of 
marijuana and other drugs because legalization would increase the availability and use of 
illicit drugs, and pose significant health and safety risks to all Americans, particularly young 
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marijuana will remain illegal under federal law in the near future.34  That 
is not the case, however, at the state level.35 
Starting in 1996, states started passing laws legalizing marijuana for 
medical or recreational use, resulting in conflicting federal and state 
marijuana policies.36  California was the first state to legalize the medical 
use of marijuana in 1996 when Proposition 215 was passed.37  Since then, 
                                                
people.”); see also Marijuana Resource Center:  State Laws Related to Marijuana, OFF. OF NAT’L 
DRUG CONTROL POL’Y (Oct. 20, 2015), https://www.whitehouse.gov/ondcp/state-laws-
related-to-marijuana [https://perma.cc/K4W9-LQ5T] (asserting the Department of Justice 
is “committed to enforcing the Controlled Substances Act (CSA)”).  But see Office of the 
Deputy Attorney General, Guidance Regarding Marijuana Enforcement, Memorandum for all 
United States Attorneys, U.S. DEP’T OF JUST. (Aug. 29, 2013), http://www.justice.gov/iso/ 
opa/resources/3052013829132756857467.pdf [https://perma.cc/A6H6-DJDQ] (advising it 
is not an efficient use of federal resources to focus federal drug enforcement efforts in states 
that have legalized marijuana in some form as long as they have “implemented strong and 
effective regulatory and enforcement systems to control the cultivation, distribution, sale, 
and possession of marijuana, conduct in compliance with those laws and regulations”). 
34 See State-By-State Medical Marijuana Laws, MARIJUANA POL’Y PROJECT, at 2 (2001), 
http://medicalmarijuana.procon.org/sourcefiles/state-by-state-guidelines-remove-threat-
of-arrest.pdf [https://perma.cc/A5EP-LB2Y] (providing that despite multiple petitions and 
“[a]fter years of litigation, it has essentially been determined the DEA will not move the 
substance into a less restrictive schedule without an official determination of ‘safety and 
efficacy’ by the U.S. Food and Drug Administration (FDA).”); see also supra note 33 and 
accompanying text (describing the opposition to rescheduling marijuana); but see S.683, 114th 
Cong. (2015) (proposing to reschedule marijuana as a Schedule II substance and amending 
the CSA to protect individuals acting in compliance with marijuana state laws from federal 
prosecution).  Senator Cory Booker of New Jersey introduced this Bill in the Senate on March 
10, 2015.  S.683–Compassionate Access, Research Expansion, and Respect States Act of 2015, 
CONGRESS.GOV (Oct. 21, 2015), https://www.congress.gov/bill/114th-congress/senate-
bill/683/actions [https://perma.cc/MCS3-VFEW].  The Bill was read twice and referred to 
the Senate Commi6ttee on the Judiciary.  Id.  The Senate’s bill House counterpart is H.R. 1538, 
and was introduced by Steve Cohen of Tennessee on March 23, 2015.  H.R. 1538–CARERS 
Act of 2015, CONGRESS.GOV (Oct. 21, 2015), https://www.congress.gov/bill/114th-
congress/house-bill/1538 [https://perma.cc/2XNN-EQAR].  H.R. 1538 was last under 
consideration by the House Subcommittee on Crime, Terrorism, Homeland Security, and 
Investigation in April.  Id.  A similar House bill is H.R. 1940, introduced April 22, 2015.  H.R. 
1940–Respect State Marijuana Laws Act of 2015, CONGRESS.GOV (Oct. 21, 2015), 
https://www.congress.gov/bill/114th-congress/house-bill/1940 [https://perma.cc/P43T-
A9KR]. 
35 See infra Part II.A.2 (summarizing recent state legislation legalizing marijuana). 
36 See Marijuana Resource Center:  State Laws Related to Marijuana, supra note 34 (indicating 
twenty-three states and Washington D.C. have legalized the medical use of marijuana since 
1996); see also State Medical Marijuana Laws, supra note 6 (asserting California was the first 
state to legalize the medical use of marijuana in 1996); State-By-State Medical Marijuana Laws, 
supra note 34, at 1, 3, 5 (providing an overview of state medical marijuana laws, federal court 
rulings, and attempts to reschedule marijuana). 
37 See State Medical Marijuana Laws, supra note 6 (asserting California became the first state 
to legalize the use of medical marijuana when voters passed Proposition 215); see also 
Hodroff, supra note 28, at 124–25 (indicating Arizona and California were the first states to 
pass laws allowing the medical use of marijuana).  Proposition 215, also known as the 
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twenty-two states, Washington D.C., and Guam have passed laws 
authorizing the medical use of marijuana.38  Furthermore, starting in 2012, 
four states and the District of Columbia passed initiatives allowing the 
sale and distribution of marijuana for recreational purposes.39  Scholars 
contend that by the end of 2016, up to another eleven states will have 
legalized marijuana.40 
In sum, today, twenty-three states and the District of Columbia have 
legalized medical marijuana.41  In addition, as of October 2015, four states 
allow the recreational use of marijuana.42  However, these laws do not 
change the fact that marijuana remains illegal under federal law.43  
Because federal law governs patent law, the federal ban on marijuana may 
affect the patentability of marijuana strains and marijuana-related 
                                                
Compassionate Use Act of 1996, specifically addressed which medical conditions were 
eligible to be treated with marijuana.  Hodroff, supra note 28, at 125.  On the other hand, 
Arizona’s initiative, Proposition 203, concerned all Schedule I substances, allowing doctors 
to prescribe Schedule I drugs to terminally ill patients under certain circumstances.  Id. 
38 See Marijuana Resource Center:  State Laws Related to Marijuana, supra note 34 (indicating 
the laws of the twenty-three states “vary greatly in their criteria and implementation” and 
that regulations on the use of marijuana may also vary at the county level).  As of October 
21, 2015, the following states and the District of Columbia allow medical marijuana:  Alaska, 
Arizona, California, Colorado, Connecticut, Delaware, Hawaii, Illinois, Maine, Maryland, 
Massachusetts, Michigan, Minnesota, Montana, Nevada, New Hampshire, New Jersey, New 
Mexico, New York, Oregon, Rhode Island, Vermont, and Washington.  State Medical 
Marijuana Laws, supra note 6. 
39 See Marijuana Resource Center:  State Laws Related to Marijuana, supra note 34 
(summarizing the status of marijuana use throughout the states).  The four states allowing 
the sale and distribution of marijuana for recreational purposes are:  Alaska, Colorado, 
Oregon, and Washington.  Id.  Colorado and Washington were the first to legalize 
recreational marijuana when voters passed Amendment 64 and Initiative 502, respectively.  
Hodroff, supra note 28, at 125–26.  Then, in 2014, Alaska passed Ballot Measure 2, the District 
of Columbia passed Initiative 71, and Oregon passed Measure 91.  See State Medical Marijuana 
Laws, supra note 6 (indicating which states allow for the retail sale and adult use of marijuana 
and providing links to the initiatives). 
40 See Christopher Ingraham, These Are the States That Could Legalize Pot Next, WASH. POST 
(July 19, 2015), http://www.washingtonpost.com/news/wonkblog/wp/2015/07/ 
19/these-are-the-states-that-could-legalize-pot-next/ [https://perma.cc/6WYU-96CC] 
(according to Ballotpedia—a website that tracks legislation—initiatives legalizing marijuana 
may appear in eleven states in 2016). 
41 See supra note 38 and accompanying text (listing the states that have legalized medical 
marijuana). 
42 See supra note 39 and accompanying text (showing the states that have legalized 
recreational marijuana).  The use of “today” refers to the time period in which this Note was 
written. 
43 See Marijuana Resource Center:  State Laws Related to Marijuana, supra note 36 (discussing 
state laws related to the medical and recreational use of marijuana and noting that these state 
laws “do not change the fact that using marijuana continues to be an offense under Federal 
law”). 
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inventions developed in states where marijuana use is otherwise legal.44  
Therefore, an overview of patent law is needed.45 
B. Patent Law Overview 
The primary sources of patent law in the United States are the 
Constitution, federal statutes and regulations, and federal judicial 
opinions interpreting and applying these statutes and regulations.46  The 
Founding Fathers recognized the importance of a patent system, granting 
Congress the power “[t]o promote the Progress of Science and useful Arts, 
by securing for limited Times to Authors and inventors the exclusive Right 
to their respective Writings and Discoveries.”47  The Patent Act of 1836 
provided the basis for the modern patent system, and the amended Patent 
Act of 1952 is the statute that governs patent law today.48 
                                                
44 See supra note 8 and accompanying text (explaining why some lawyers think the USPTO 
will not issue patents protecting marijuana strains based on marijuana’s status as an illegal 
substance under federal law). 
45 See infra Part II.B (discussing the requirements for patentability and the different types 
of patents available). 
46 See JANICE M. MUELLER, PATENT LAW 31 (2009) (listing the sources of patent law).  The 
Patent Act of 1952, the basis of the modern patent system, was codified in Title 35 of the 
United States Code.  Id. at 33–34.  The sections of the code that “impact the operations of the 
[USPTO] are implemented through the agency’s governing regulations.”  Id. at 34.  These 
regulations are in Title 37 of the Code of Federal Regulations.  Id.  Furthermore, the USPTO 
publishes the Manual of Patent Examining Procedure (“MPEP”), which outlines the laws 
and regulations patent examiners follow when examining patent applications.  Id.  However, 
the MPEP is simply an operations manual for patent examiners and, therefore, does not have 
“the force and effect of the law.”  Id.  Nonetheless, it is a useful resource for patent attorneys, 
and courts are willing to give the MPEP “judicial notice” to the extent that it does not conflict 
with the Patent Act.  In re Fisher, 421 F.3d 1365, 1372 (Fed. Cir. 2005). 
47 U.S. CONST. art. I, § 8, cl. 8.  District courts have original jurisdiction over cases that 
“arise under any Act of Congress relating to patents[,]” according to 28 U.S.C § 1338, and the 
U.S. Court of Appeals for the Federal Circuit (“CAFC”) has exclusive jurisdiction over 
appeals from final decisions of district courts relating to patents.  28 U.S.C. § 1295 (2012).  
Before Congress created the CAFC in 1982, the “appropriate federal regional circuit court of 
appeals for the federal district court in question” would review appeals of judgments in 
patent cases.  MUELLER, supra note 46, at 38.  The CAFC was formed by merging the U.S. 
Court of Customs and Patent Appeals and the appellate division of the U.S. Court of Claims.  
U.S. Court of Appeals for the Federal Circuit, Court Jurisdiction (Oct. 23, 2015), 
http://www.cafc.uscourts.gov/the-court/court-jurisdiction [https://perma.cc/B28J-
63BA].  The CAFC adopted as binding precedent the decisions of both of its predecessor 
courts.  MUELLER, supra note 46, at 34.  In addition, the en banc court of the CAFC can “change 
the law or overrule existing precedent.”  Id.  Nonetheless, the U.S. Supreme Court can review 
the CAFC’s decisions.  Id. 
48 See MUELLER, supra note 46, at 33 (summarizing the history and development of the 
Patent System in the United States).  The first patent statute passed by Congress was the 
Patent Act of 1790; however, the Patent Act of 1836 provided the basis for the modern patent 
system.  EDWARD C. WALTERSCHEID, TO PROMOTE THE PROGRESS OF USEFUL ARTS:  AMERICAN 
PATENT LAWS AND ADMINISTRATION, 1798-1836 1, 3 (1998.  See also PAUL GOLDSTEIN & R. 
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The USPTO grants three types of patents:  utility patents, design 
patents, and plant patents.49  First, Part II.B.1 examines the three different 
types of patents and explains the statutory requirements for patent 
protection.50  Next, Part II.B.2 provides an overview of the patent 
prosecution process.51 
1. Types of Patents and Requirements for Protection 
The majority of the patents issued by the USPTO are utility patents.52  
Utility patents protect the way an invention is used and the way it works.53  
Further, utility patents have a term of twenty years from the date on which 
the application was filed and afford the patentee the right to exclude 
others from making, using, offering to sell, or selling the patented 
invention in the United States, as well as the right to exclude others from 
importing the patented invention into the United States.54 
                                                
ANTONY REESE, COPYRIGHT, PATENT, TRADEMARK AND RELATED STATE DOCTRINES 416 (2012) 
(providing a historical overview of patent legislation).  The Patent Act of 1793 repealed the 
Patent Act of 1790.  WALTERSCHEID, supra note 48, at 3.  Before the Patent Act of 1836, four 
other patent acts were passed.  Id.  The other two main revisions to the patent statute are the 
Patent Act of 1870 and the Leahy-Smith America Invents Act (“AIA”) in 2011.  MUELLER, 
supra note 46, at 33; GOLDSTEIN & REESE, supra note 48, at 416.  The Patent Act of 1870 
introduced the requirement that patent applicants include claims.  MUELLER, supra note 46, 
at 33.  On the other hand, the AIA modified the patent prosecution process, changed the rules 
for the novelty requirement, and revised the priority determination from first to invent to 
first inventor to file.  GOLDSTEIN & REESE, supra note 48, at 453, 483–84, 562–63. 
49 See GOLDSTEIN & REESE, supra note 48, at 418, 419 (indicating that the Patent Act 
authorizes utility patents, design patents, and plant patents). 
50 See infra Part II.B.1 (describing the different types of patents and outlining the 
conditions for patentability). 
51 See infra Part II.B.2 (explaining the patent prosecution process). 
52 See U.S. Patent Statistics, Calendar Years 1963–2014 (Oct. 23, 2015), 
http://www.uspto.gov/web/offices/ac/ido/oeip/taf/us_stat.pdf [https://perma.cc/ 
N9QG-T7YY] (reporting the number of patent applications received and granted according 
to the type of patent and calendar year).  In 2014, the USPTO granted a total of 326,033 
patents, 300,677 of which were utility patents.  Id. 
53 See Design Patent Application Guide, U.S. PAT. & TRADEMARK OFF. (Oct. 26, 2015), 
http://www.uspto.gov/patents-getting-started/patent-basics/types-patent-
applications/design-patent-application-guide [https://perma.cc/FLJ5-TP4G] (explaining 
the differences between design and utility patents); Manual of Patent Examining Procedures 
§ 1502.01 (Nov. 2015), http://www.uspto.gov/web/offices/pac/mpep/s1502.html 
[https://perma.cc/G9VL-X8XU] (summarizing the differences between utility and design 
patents). 
54 See 35 U.S.C. § 154(a)(2) (2012) (providing the term of patents); § 271 (establishing the 
acts that constitute infringement of a patent); Manual of Patent Examining Procedures § 1502.01, 
supra note 53 (stating that for the patents issued on applications filed on or after June 8, 1995, 
the term of the patent starts on the date the patent issues, but ends twenty years from the 
date on which the patent application was filed).  If an application contains a reference to an 
earlier filed application or applications under §§ 120, 121, or 365(c), the term of the patent 
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To be patentable under a utility patent, the subject matter of an 
invention must qualify for a patent and the invention must be new, useful, 
and nonobvious.55  The first requirement for patentability is that the 
subject matter of the invention qualify as patent-eligible subject matter.56  
The types of inventions that qualify as patent-eligible subject matter are 
listed in 35 U.S.C. § 101 and are processes, machines, manufactures, and 
compositions of matter.57  Nonetheless, courts have narrowed the 
otherwise broad scope of patentable subject matter by recognizing three 
                                                
ends on the date on which the earliest application was filed.  § 154(a)(2). 
55 See § 101 (listing the inventions patentable and providing the basis for the utility 
requirement); § 102 (establishing the novelty requirement); § 103 (formulating the 
nonobviousness requirement).  Utility patents must also satisfy the written description and 
specification requirements set forth in 35 U.S.C. §§ 111, 112.  MUELLER, supra note 46, at 97.  
The requirements imposed by 35 U.S.C. § 112 are known as the disclosure requirements and 
include the enablement, best mode, and written description of the invention requirements.  
Id.  These requirements, however, “pertain to the informative quality of the patent 
application rather than the technical merits of the claimed invention.”  Id.  Thus, they are 
beyond the scope of this Note.  It is sufficient to understand that these disclosure 
requirements arise from the quid pro quo contemplated by Congress for granting a patent 
monopoly.  Id.  In other words, the government agrees to give the patentee a limited 
monopoly over his or her invention in exchange for a sufficiently detailed and clear 
disclosure of the invention.  Id. 
56  See Manual of Patent Examining Procedures § 2106 (Nov. 2015), http://www.uspto.gov/ 
web/offices/pac/mpep/s2106.html#d0e197244 [https://perma.cc/P85Z-G97Y] (stating 
that a claimed invention must be directed to patent-eligible subject matter); MUELLER, supra 
note 46, at 253–55 (discussing potentially patentable subject matter and indicating that 
subject matter eligibility refers to the categories of subject matter enumerated in § 101); see 
also In re Bilski, 545 F.3d 943, 950 (Fed. Cir. 2008) (“Whether a claim is drawn to patent-eligible 
subject matter under § 101 is a threshold inquiry, and any claim of an application failing the 
requirements of § 101 must be rejected even if it meets all of the other legal requirements of 
patentability . . . .”). 
57 See § 101 (providing for the inventions patentable under the Patent Act); see also § 100 
(defining “process” as meaning “process, art or method, and includes a new use of a known 
process, machine, manufacture, composition of matter, or material”).  Courts have 
interpreted “manufacture” to mean “the production of articles for use from raw materials 
prepared by giving to these materials new forms, qualities, properties, or combinations, 
whether by hand labor or machinery.”  Am. Fruit Growers, Inc. v. Brogdex Co., 283 U.S. 1, 
11 (1931).  “Machine” refers to “a concrete thing, consisting of parts, or of certain devices and 
combination of devices.”  Burr v. Duryee, 68 U.S. 531, 570 (1863).  Further, newly developed 
plants qualify as patent-eligible subject matter.  J.E.M. AG Supply, Inc. v. Pioneer Hi-Bred 
Int’l, Inc., 122 S. Ct. 593, 596 (2001); MUELLER, supra note 46, at 288 n.157 (indicating plants 
may be eligible for protection under utility patents); General Information about 35 U.S.C § 161 
Plant Patents, U.S. PAT. & TRADEMARK OFF. (Oct. 23, 2015), http://www.uspto.gov/patents-
getting-started/patent-basics/types-patent-applications/general-information-about-35-
usc-161 [https://perma.cc/8P6B-6NF8].  Lastly, “composition of matter” has been construed 
as including “all compositions of two or more substances and . . . all composite articles, 
whether they be the results of chemical union, or mechanical mixture, or whether they be 
gases, fluids, powders, or solids.”  Shell Dev. Co. v. Watson, 149 F. Supp. 279, 280 (D.C. Cir. 
1957). 
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exceptions to § 101.58  These three exceptions are:  laws of nature, physical 
phenomena, and abstract ideas.59  However, applications of these judicial 
exceptions qualify for patent protection.60  Subject matter eligibility is just 
the first hurdle an applicant must clear to patent his or her invention.61 
The second statutory requirement is that the invention be new, which 
is also known as the novelty requirement.62  The test to determine whether 
an invention is new is set forth in 35 U.S.C. § 102(a) and requires 
determining whether an invention has been anticipated.63  An invention 
is anticipated, and not novel, if the prior art is identical to the invention.64  
Specifically, a single prior art reference must disclose every element of the 
invention.65  Even if a prior art reference does not entirely disclose the 
                                                
58 See Diamond v. Chakrabarty, 447 U.S. 303, 309 (1980) (clarifying that even though 
legislative history supports a broad construction of § 101, it does not follow that § 101 “has 
no limits or that it embraces every discovery”). 
59 See id. (“[L]aws of nature, physical phenomena, and abstract ideas have been held not 
patentable . . . .”).  For example, a new mineral discovered in the earth, a new plant found in 
the wild, or mathematical formulas are not patentable.  Id. 
60 See Diamond v. Diehr, 450 U.S. 175, 187 (1981) (“[A]n application of a law of nature or 
mathematical formula to a known structure or process may well be deserving of patent 
protection.”); Manual of Patent Examining Procedures § 2106, supra note 56 (“While abstract 
ideas, physical phenomena, and laws of nature are not eligible for patenting, methods and 
products employing abstract ideas, physical phenomena, and laws of nature to perform a 
real-world function may well be.”). 
61 See supra note 55 and accompanying text (listing all the requirements for patentability). 
62 See § 101 (“Whoever invents or discovers any new and useful process, machine, 
manufacture, or composition of matter, or any new and useful improvement thereof, may 
obtain a patent thereof . . . .”) (emphasis added). 
63 See MUELLER, supra note 46, at 138 (indicating that attorneys say an invention has been 
anticipated if the novelty provisions of § 102 are triggered).  An invention is also not novel if 
it was “in public use, on sale, or otherwise available to the public before the effective filing 
date of the claimed invention . . . .”  § 102(a)(1).  The AIA significantly revised Section 102.  
Manual of Patent Examining Procedures § 2150 (Nov. 2015), http://www.uspto.gov/web/ 
offices/pac/mpep/s2150.html [https://perma.cc/8J7E-B89T].  Before the AIA was passed, 
§§ 102(a)–(g) established the test for novelty.  Id.  These provisions still apply to patent 
applications filed before March 16, 2013.  Id.  The most significant change to § 102 under the 
AIA is “when and where an event must occur in order to anticipate, and which events will 
anticipate . . . .”  GOLDSTEIN & REESE, supra note 48, at 457.  The changes and the differences 
between pre-AIA and AIA § 102, however, are beyond the scope of this Note. 
64 See GOLDSTEIN & REESE, supra note 48, at 456 (asserting § 102 bars a patent if the prior 
art anticipates the invention, and the prior art anticipates the invention if it is identical to the 
invention).  Section 102 also specifies what constitutes prior art.  See § 102(a)(1) (providing 
patents and printed publications are prior art); § 102(b) (denoting what types of disclosures 
do not constitute prior art under § 102(a)); § 102(d) (stipulating when a patent is effective as 
prior art). 
65 See In re Crish, 393 F.3d 1253, 1256 (Fed. Cir. 2004) (stating that determining whether a 
claim is anticipated involves two steps:  first, interpreting the claim language and second, 
comparing the construed claim to prior art references and making factual findings that “each 
and every limitation is found either expressly or inherently in that [a] single prior art 
reference”); GOLDSTEIN & REESE, supra note 48, at 456 (specifying under § 102, a single prior 
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invention, the invention may nonetheless be unpatentable if the 
differences would have been obvious to a person having ordinary skill in 
the art (“PHOSITA”).66  The third requirement, known as the non-
obviousness requirement, deals with such a situation.67 
The non-obviousness requirement for patentability is set forth in § 103 
of the Patent Act.68  Under § 103, an invention is not patentable if it was 
obvious to a PHOSITA before the effective filing date of the patent 
application.69  Thus, the test for obviousness is whether “the differences 
between the claimed invention and the prior art are such that the claimed 
invention as a whole would have been obvious . . . to a [PHOSITA] to 
which the claimed invention pertains.”70  Even if nonobvious, the 
invention may be unpatentable if it does not satisfy the utility 
requirement.71 
                                                
art reference must disclose all the elements of the invention). 
66 See Manual of Patent Examining Procedures § 2141 (Mar. 2014), http://www.uspto.gov/ 
web/offices/pac/mpep/s2141.html [https://perma.cc/753Z-9SAP] (commenting that a 
patent may not be obtained, even if the invention is novel under § 102, if the invention would 
have been obvious to a person having ordinary skill in the art); MUELLER, supra note 46, at 
191–92 (noting the language of § 103 indicates that the obviousness requirement must be 
satisfied even if an invention is not anticipated under § 102). 
67 See § 103 (providing an invention is not patentable if obvious to person having ordinary 
skill in the art (“PHOSITA”)). 
68 See id. (establishing the non-obvious subject matter condition for patentability); see also 
MUELLER, supra note 46, at 191 (noting the non-obviousness requirement had been 
recognized in patent case law since 1851, but was not codified as § 103 until the Patent Act 
of 1952). 
69 See 35 U.S.C. § 103 (“A patent for a claimed invention may not be obtained . . . if . . . the 
claimed invention . . . would have been obvious before the effective filing date of the claimed 
invention to a person having ordinary skill in the art . . . .”). 
70 Id.  See also Graham v. John Deere Co., 383 U.S. 101, 103 (1966) (citing § 103 as providing 
the test for obviousness).  In Graham, the Supreme Court’s seminal decision concerning 
obviousness, the Court set forth the factors to be assessed in determining whether an 
invention would have been obvious to a PHOSITA.  See MUELLER, supra note 46, at 196 
(noting Graham is a landmark opinion); Manual of Patent Examining Procedures, supra note 66, 
at § 2141 (describing the recent Supreme Court’s decision in KSR Int’l Company v. Teleflex Inc., 
550 U.S. 398 (2007)), which reaffirmed the obviousness framework set forth in Graham).  In 
Graham, the court held that the obviousness of the invention is determined by considering:  
the scope and content of the prior art, the differences between the prior art and the claims at 
issue, and the pertinent level of the ordinary skill in the art.  383 U.S. at 17.  Furthermore, 
courts can take into account secondary considerations, such as commercial success, long felt 
but unsolved needs, and failure of others to solve the need.  Id. at 17–18. 
71 See § 101 (indicating an invention must be useful to be patentable); but see Lee v. Dayton-
Hudson Corp., 838 F.2d 1186, 1188 (Fed. Cir. 1988) (holding design patents are not subject to 
the utility requirement). 
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An applicant is not entitled to a patent on his invention unless the 
invention is useful.72  An invention is useful if it possesses utility.73  
Although the utility requirement is established by 35 U.S.C. § 101, neither 
this section nor the Patent Act explains what utility means, and thus, case 
law is the source of utility principles.74  Historically, Justice Joseph Story’s 
instructions to the jury in Lowell v. Lewis are recognized as the first 
articulation of a definition of utility.75  In charging the jury, Justice Story 
stated, “[a]ll that the law requires is, that the invention should not be 
frivolous or injurious to the well-being, good policy, or sound morals of 
society.”76  This definition came to be known as the “moral-utility 
doctrine.”77  Thereafter, Justice Story’s definition would be used to 
invalidate patents for lack of moral utility in two types of cases:  inventions 
to deceive or commit fraud and inventions used for gambling.78 
                                                
72 See U.S. CONST. art. I, § 8, cl. 8 (“To promote the progress of science and useful arts, by 
securing for limited times to authors and inventors the exclusive right to their respective 
writings and discoveries . . . .”) (emphasis added); § 101 (“Whoever invents or discovers any 
new and useful process, machine, manufacture or composition of matter . . . may obtain a 
patent thereof . . . .”). 
73 See MUELLER, supra note 46, at 235 (noting that a useful invention possesses utility). 
74 See id. (explaining the Patent Act does not define what useful means, and thus, case law 
fills this gap). 
75 See Margo A. Bagley, Patent First, Ask Questions Later:  Morality and Biotechnology in 
Patent Law, 45 WM. & MARY 469, 489 (2003) (“Justice Story is credited with the first 
articulation of the [utility] doctrine . . . .”); Andrew R. Smith, Note, Monsters at the Patent 
Office:  The Inconsistent Conclusions of Moral Utility and the Controversy of Human Cloning, 53 
DEPAUL L. REV. 159, 164 (2003) (“Justice Story enunciated the first interpretation of the term 
‘useful’ within the 1970 Act.”). 
76 Lowell v. Lewis, 15 F. Cas. 1018, 1019 (C.C.D. Mass. 1817).  Justice Joseph Story further 
explained that the word “useful” was incorporated into the Patent Act “in contradistinction 
to mischievous or immoral.”  Id.  Examples of inventions that would not satisfy the utility 
requirement, Justice Story stated, are inventions to poison people, promote debauchery, or 
facilitate private assassination.  Id.  In Lowell, the plaintiff sued the defendant for 
infringement of an improvement in the construction of pumps.  Id.  At issue was the utility 
of the invention.  Id.  The court concluded that the plaintiff’s invention was useful because 
there was no evidence that the invention was mischievous.  Id.  The court further rejected the 
defendant’s contention that to satisfy the utility requirement, the plaintiff’s pump had to be 
better than previous pumps.  Id.  Justice Story explained that whether the invention is more 
or less useful is immaterial in determining an invention’s utility.  Lowell, 15 F. Cas. at 1019. 
77 See Bagley, supra note 75, at 490 (asserting Justice Joseph Story’s words in Lowell 
provided the foundation for the “moral utility” doctrine); Benjamin D. Enerson, Note, 
Protecting Society from Patently Offensive Inventions:  The Risk of Reviving the Moral Utility 
Doctrine, 89 CORNELL L. REV. 685, 690 (2004) (denoting Justice Story’s definition in Lowell is 
referred to as the moral utility doctrine); Gary Gregory, Note, What’s Immoral about Monsanto:  
Strengthening the Roots of the Moral Utility Requirement by Amending the U.S. Patent Act, 21 
CARDOZO J. INT’L & COMP. L. 759, 771 (2013) (indicating Justice Story’s words in Lowell are 
known as the “moral utility requirement”). 
78 See Laura A. Keay, Morality’s Move within U.S. Patent Law:  From Moral Utility to Subject 
Matter, 40 AIPLA Q.J. 409, 412 (2012) (noting Justice Story’s definition was used to invalidate 
two types of patents:  “gambling devices ‘injurious’ to the moral of society” and “inventions 
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More recently, however, since the Supreme Court’s decision in 
Brenner v. Manson, courts have defined utility in terms of specific and 
substantial utility.79  To begin, in In re Fisher, the Federal Circuit elaborated 
on the meaning of specific and substantial utility.80  Fisher indicated that 
to satisfy the substantial utility prong, “an asserted use must show that 
that claimed invention has a significant and presently available benefit to 
the public.”81  Furthermore, to satisfy the specific utility prong, “an 
                                                
with a mischievous tendency”); Thomas A. Magnani, The Patentability of Human-Animal 
Chimeras, 14 BERKELEY TECH. L.J. 443, 451 (1991) (stating that courts have applied Justice 
Story’s definition in two specific cases:  inventions used to deceive or commit fraud and 
gambling devices and other inventions frowned upon by society).  From 1889 to the early 
1990s, courts cited some version of Justice Story’s definition of utility to invalidate patents 
on gambling-related inventions.  Keay, supra note 78, at 412–15.  Specifically, courts 
invalidated patents for devices that could only be used for gambling purposes or could be 
used for other purposes but were currently being used for gambling.  Id.  For example, in 
National Automatic Device Co v. Lloyd, the Northern District of Illinois invalidated a patent 
covering a “Toy Automatic Race-Course.” 40 F. 89, 89–90 (C.C.N.D. Ill. 1889).  The court 
reasoned that the invention lacked utility because, so far, it had only been used for the 
“pernicious and hurtful” purpose of gambling.  Id. at 90.  See also Brewer v. Lichtenstein, 278 
F. 512, 513–14 (7th Cir. 1922) (affirming a district court’s decision to dismiss an infringement 
action of a patent covering a vending device); Meyer v. Buckley Mfg. Co., 15 F. Supp. 640, 
641 (D.C.N.D. Ill. 1936) (invalidating a patent for a vending machine for lack of utility 
because it was “a device for playing a game of chance”); Schultze v. Holtz, 82 F. 448, 448–49 
(C.C.N.D. Cal. 1897) (invalidating a patent claiming a coin-controlled apparatus); Reliance 
Novelty Co. v. Dworzek, 80 F. 902, 903–04 (C.C.N.D. Cal. 1897) (denying a preliminary 
injunction in an infringement action of a patent on slot machines because the device lacked 
utility).  In Reliance Novelty, the court reasoned that the device lacked utility because it had 
only been used for gambling purposes.  80 F. at 903.  Similarly, in Schultze, the court 
concluded the device lacked utility because it had and could only be used for gambling 
purposes.  82 F. at 449.  Last, in Brewer, the court reasoned that the device lacked utility 
because it could only be used as a lottery device.  278 F. at 513.  Concerning deceptive 
inventions, in Rickard v. Du Bon, the Second Circuit affirmed the district court’s decision to 
invalidate a patent claiming a method for treating tobacco leaves to cause spotting.  103 F. 
868, 869, 873 (2d Cir. 1990).  At the time of the invention, there was a notion among smokers 
that spotted tobacco was of higher quality.  Id. at 869.  The court concluded the invention 
lacked utility because it could not improve the quality of the tobacco, and thus, the spotting 
was deceiving to buyers.  Id. at 872.  Further, the court noted that patents could not be granted 
on inventions that encouraged profiting by deception and fraud.  Id. at 873. 
79 See 383 U.S. 519, 534 (1966) (concluding that the “basic quid pro quo contemplated by 
the Constitution and the Congress for granting a patent monopoly is the benefit derived by 
the public from an invention with substantial utility”).  At issue in Brenner was the utility of 
a process for making steroids.  Id. at 520.  Even though the process yielded a steroid closely 
related to a steroid with known utility, the court denied the patent for lack of utility.  Id. at 
534–35.  The court concluded that the applicant was unable to show the product that the 
process yielded was substantially useful.  Id. 
80 See 421 F.3d 1365, 1371 (Fed. Cir. 2005) (defining specific and substantial utility).  In In 
re Fisher, the Federal Circuit affirmed the USPTO Board of Patent Appeals and Interference’s 
decision finding claims for “expressed sequence tags” unpatentable for lack of utility.  Id. at 
1367. 
81 Id. at 1371. 
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asserted use must also show that that claimed invention can be used to 
provide a well-defined and particular benefit to the public.”82 
Even though courts have criticized Justice Story’s definition of utility 
and expressly rejected the application of the doctrine to gambling and 
deceptive devices, no court has expressly foreclosed the application of the 
moral utility doctrine to cases outside the realm of gambling and 
deceptive devices.83  Scholars, however, propose that the moral utility 
                                                
82 Id. 
83 See Smith, supra note 75, at 186 (“Although no judicial opinion has dismissed moral 
utility entirely, its direct application to patentable utility is severely limited.”).  The decline 
of the application of the moral utility doctrine started in 1903, with Fuller v. Berger.  Smith, 
supra note 75, at 165–66.  In Fuller, the Seventh Circuit refused to invalidate a patent covering 
a bogus coin detector used to guard gambling machines.  120 F. 274, 274, 278 (7th Cir. 1903).  
In finding the device possessed the requisite utility, the court defined utility as requiring that 
an invention serve some “beneficial end.”  Id. at 275.  The Fuller court placed high importance 
on the fact that the invention, even though only used in association with gambling devices 
at the time, was (1) not originally designed to be used with gambling devices; (2) could be 
used for purposes other than with gambling devices; and (3) when used with gambling 
devices, it was not connected to the gambling device and thus had no element of chance to 
it.  Id. at 276.  Following this decision, in Chicago Patent Corp. v. Cenco, Inc., the Seventh Circuit 
concluded a pin-ball machine was useful because it could not say “as a matter of law” that 
the machine was “inherently a gambling device.”  124 F.2d 725, 728 (7th Cir. 1941).  Similarly, 
the Tenth Circuit, in Callison v. Dean, concluded an amusement device was useful because it 
could be used for innocent amusement purposes.  70 F.2d 55, 58 (10th Cir. 1934).  Then, in 
1947, the Third Circuit applied Justice Story’s definition of utility in Cusano v. Kottler to 
conclude that a gaming table satisfied the utility requirement.  159 F.2d 159, 162 (2d Cir. 
1947).  Although the court took into consideration the gaming aspects of the invention, the 
court ultimately reasoned that it was useful because it did not have to be used for gambling 
purposes.  Id. at 161–62.  Subsequently, in Ex parte Murphy, the USPTO Board of Appeals 
reversed an examiner’s determination that a slot machine patent lacked utility because it 
could only be used for gambling.  200 U.S.P.Q. 80 (P.O. Bd. App. 1977).  The Board reasoned 
that the USPTO should not be the agency responsible for enforcing morality with respect to 
gambling, and thus, concluded “inventions which are useful only for gambling ipso facto” 
were not “void of patentable utility.”  Id.  Thus, Ex parte Murphy expressly rejected the 
application of the moral utility doctrine to gambling devices.  Id.  On the other hand, Whistler 
Corp. v. Autotronics, Inc. was the first case that did not apply the doctrine to invalidate patents 
covering inventions used to deceive or commit fraud.  No. CA3–85–2573–D, 1988 WL 212501, 
at *1 (N.D. Tex. July 28, 1988).  Here, the court concluded a radar signal detector was useful 
despite being used to circumvent the law.  Id.  Next, in Juicy Whip, Inc. v. Orange Bang, Inc., 
the Federal Circuit held that inventions could not be held unpatentable for lack of utility 
“simply because they have the capacity to fool some members of the public.”  185 F.3d 1364, 
1368 (Fed. Cir. 1999).  Similar to the court’s reasoning in Ex parte Murphy, the court noted that 
the utility requirement was not a command to the USPTO or the courts to aid as “arbiters of 
deceptive trade practices.”  Id.  Therefore, Juicy Whip marked the end of the application of 
the moral utility doctrine to invalidate inventions designed to deceive or commit fraud.  Id.  
In Brenner, the court critiqued Justice Story’s definition for two reasons.  383 U.S. at 533.  First, 
the court explained that, when read narrowly, the definition compelled the court to 
determine whether an invention was “frivolous and insignificant,” a task difficult to do.  Id.  
On the other hand, when read broadly, it would “allow the patenting of any invention not 
positively harmful to society.”  Id.  According to the court, this broad reading gave the word 
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doctrine is no longer good law.84  Nonetheless, courts have not expressly 
examined whether morality or illegality should be taken into 
consideration when determining whether an invention provides some 
specific and substantial benefit to the public under Brenner and In re 
Fisher’s definitions.85 
In fact, the only time a court has, post-Brenner, alluded to how 
illegality would affect the patentability of an invention was in Whistler 
Corp. v. Autotronics, Inc.86  Holding that a radar signal detector was 
patentable even though the primary and almost exclusive use of the 
device was to circumvent law enforcement, the court concluded, “[u]nless 
and until detectors are banned outright, or Congress acts to withdraw 
patent protection for them, radar detector patentees are entitled to the 
protection of the patent laws.”87  Similarly, but before Brenner was 
decided, in Fuller v. Berger, the court rejected an accused infringer’s 
argument that the court should deny an injunction because the invention 
could only be used for illegal purposes under state law.88  Fuller further 
concluded that even though state laws prevented the patentee from 
practicing his invention, they did not affect his right to exclude others 
from using the invention where legal.89  Nevertheless, neither courts nor 
                                                
“useful” a meaning Congress did not intend.  Id.  In In re Fisher, the Federal Circuit stated the 
“Supreme Court appeared to reject Justice Story’s de minimis view of utility” in Brenner.  421 
F.3d at 1370 (emphasis added). 
84 See generally Bagley, supra note 75, at 492 (noting the moral utility doctrine has “suffered 
a judicial demise”); Enerson, supra note 77, at 691 (claiming “the moral utility doctrine is not 
completely dead”); Gregory, supra note 77, at 762 (arguing for the implementation of a more 
strict patent application process that would revitalize the “weakened” moral utility doctrine) 
(emphasis added); Cynthia M. Ho, Splicing Morality and Patent Law:  Issues Arising from 
Mixing Mice and Men, 2 WASH. U. J.L. & POL’Y 247, 249 (2000) (noting no court has relied on 
the moral utility doctrine since 1977); Keay, supra note 78, at 411 (indicating the decline of 
the moral utility doctrine after its prominence in the twentieth century); Magnani, supra note 
78, at 453 (reasoning the moral utility doctrine is defunct based on the district courts’ attitude 
towards the doctrine); Dana Visser, Note, Who’s Going to Stop Me from Patenting My Six-
Legged Chicken? An Analysis of the Moral Utility Doctrine in the United States, 46 WAYNE L. REV. 
2067, 2070, 2086 (2000) (observing that the cases on the moral utility doctrine appear 
contradictory and it is unclear whether the doctrine has been repudiated). 
85 See In re Fisher, 421 F.3d at 1371 (defining specific and substantial utility in terms of 
significant, presently available, particular, and well-defined benefit to the public, but 
providing no guidance on what should be considered in determining if an invention 
provides a benefit to the public). 
86 See Civ. A. No. CA3-85-2573-D, 1988 WL 212501, at *1 (N.D. Tex. 1988) (considering the 
patentability of a radar signal detector used to circumvent the law).  The court held that a 
radar signal detector, used primarily to circumvent the law, had patentable utility.  Id.  The 
court reasoned that only Congress could withdraw patent protection for such devices.  Id. 
87 Id. 
88 See Fuller, 120 F. at 275–76 (providing anything used to accomplish a good result is 
useful, even if it can be used and is in fact “oftener” used to accomplish bad results). 
89 See id. at 279 (“[A] state law which prohibits the use of a certain article, which is 
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the USPTO have directly addressed or determined whether an invention 
lacks patentable utility if it can be used for illegal purposes.90 
The second type of patents the USPTO grants are design patents.91  
Under the Patent Act, “[w]hoever invents any new, original[,] and 
ornamental design for an article of manufacture may obtain a patent 
therefor . . . .”92  Specifically, design patents protect the ornamental or 
aesthetic features of an invention.93  A design patent has a term of 
“fourteen years from the date of grant” and affords the patentee the right 
to exclude others from making, using, offering to sell, or selling the 
patented design in the United States, as well as the right to exclude others 
from importing the patented design into the United States.94  Design 
patent applications are subject to the same patentability requirements of 
utility patent applications discussed above, except for the utility 
requirement.95 
                                                
patented, is not in derogation of the inventor’s grant under the patent law.”).  Most recently, 
in Juicy Whip, Inc. v. Orange Bang, Inc., the Federal Circuit reversed a district court’s decision 
that a post-mix beverage dispenser designed to look like a pre-mix beverage dispenser was 
not useful because its purpose was to increase sales by deception.  185 F.3d 1364, 1368 (Fed. 
Cir. 1999).  The court indicated “Congress is free to declare particular types of inventions 
unpatentable for a variety of reasons, including deceptiveness.”  Id.  Thus, the court 
concluded it could not hold the device unpatentable for lack of utility simply because it had 
the capacity to fool consumers.  Id.  Further, while the court in Juicy Whip, Inc. referred to 
Justice Story’s definition when defining utility—also noting that “it has not been applied 
broadly in recent years”—it did not expressly reject it.  Id. at 1366–67.  See also Brenner v. 
Manson, 383 U.S. 519, 532–33 (1966) (criticizing Justice Story’s definition of utility for 
shedding little light on the issue of utility in the context of chemical process claims); In re 
Fisher, 421 F.3d at 1370 (rejecting the applicant’s argument for utility under Justice Story’s 
definition). 
90 See Manual of Patent Examining Procedures § 2107.01 (Mar. 2014), 
http://www.uspto.gov/web/offices/pac/mpep/s2107.html [https://perma.cc/SMP7-
DNXB] (instructing examiners to analyze patentable utility under the principles established 
in In re Fisher, but making no mention of morality or illegality in determining an invention’s 
benefit to the public); Smith, supra note 75, at 173 (pointing out that it is unclear what effect 
the illegality of an invention would have on an evaluation of patentable utility). 
91 See GOLDSTEIN & REESE, supra note 48, at 418–19 (2012) (explaining the differences 
between the types of patents granted by the USPTO). 
92 35 U.S.C. § 171 (2012). 
93 See Carman Indus., Inc. v. Wahl, 724 F.2d 932, 939 n.13 (Fed. Cir. 1983) (“Utility patents 
afford protection for the mechanical structure and function of an invention whereas design 
patent protection concerns the ornamental or aesthetic features of a design.”); Manual of 
Patent Examining Procedures § 1502.01, supra note 53 (distinguishing the features utility and 
design patents protect). 
94 See 35 U.S.C. § 173 (establishing the term of design patents); § 271 (establishing the acts 
that constitute infringement of a patent). 
95 See § 171 (“The provisions of this title relating to patents for inventions shall apply to 
patents for designs, except as otherwise provided.”).  Design patent protection does not 
extend to features of the design that are functional.  See Lee v. Dayton-Hudson Corp., 838 
F.2d 1186, 1188 (Fed. Cir. 1988) (“Design patents do not and cannot include claims to the 
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The last type of patents the USPTO grants are plant patents.96  Anyone 
who “invents or discovers and asexually reproduces any distinct and new 
variety of plant . . . may obtain a patent therefor . . . .”97  If granted, the 
patent covers the entire plant and lasts for a term of twenty years from the 
date on which the application was filed.98  The patent also affords the 
patentee the right to “exclude others from asexually reproducing the 
plant, and from using, offering for sale, or selling the plant so reproduced, 
or any of its parts[,]” as well as the right to exclude others from “importing 
the plant so reproduced, or any parts thereof, into the United States.”99  
Plant patent applications are subject to the same patentability 
requirements of utility patent applications discussed above.100 
                                                
structural or functional aspects of the article . . . .”).  Further, if the design of the invention is 
primarily functional, the design lacks ornamentality and is, therefore, not patentable subject 
matter under § 171.  Design Patent Application Guide, supra note 53.  Because design patents 
cannot encompass functional features, design patents do not have to satisfy the utility 
requirement set forth in § 101.  Lee, 838 F.2d at 1188.  Nonetheless, design patents must satisfy 
the novelty, non-obviousness, application, and specification requirements set forth in §§ 102, 
103, 111, and 112.  See id. (citing 35 U.S.C. § 171, which indicates that design patents are also 
subject to the other patentability requirements outlined in Title 35). 
96 See GOLDSTEIN & REESE, supra note 48, at 418–19 (providing the three types of patents 
granted by the USPTO). 
97 § 161.  The Act includes plant patent protection for “cultivated sports, mutants, hybrids, 
and newly found seedlings, other than a tuber propagated plant or a plant found in an 
uncultivated state . . . .”  Id.  A plant is asexually reproduced when a genetically identical 
copy of the plant is created without using seeds.  General Information about 35 U.S.C § 161 
Plant Patents, supra note 57; MUELLER, supra note 46, at 288.  Known methods of asexual 
reproduction include:  tissues culture, layering, granting and budding, and nuclear embryos.  
General Information about 35 U.S.C. § 161 Plant Patents, supra note 57.  Although not covered 
by plant patents, sexually reproduced plant varieties can be protected under the Plant 
Variety Protection Act.  MUELLER, supra note 46, at 288.  However, plants that reproduce 
sexually are eligible for plant patent protection if they are asexually reproduced.  Manual of 
Patent Examining Procedures § 1601 (Nov. 2015), http://www.uspto.gov/web/offices/pac/ 
mpep/s1601.html [https://perma.cc/T3AS-ED9Y].  Further, both asexually and sexually 
reproduced plants are eligible for protection under utility patents.  J.E.M. AG Supply, Inc. v. 
Pioneer Hi-Bred Int’l, Inc., 534 U.S. 124, 145 (2001).  See MUELLER, supra note 46, at 288 n.157 
(noting plants may be eligible for protection under utility patents). 
98 General Information Concerning Patents, U.S. PAT. & TRADEMARK OFF. (Oct. 23, 2015), 
http://www.uspto.gov/patents-getting-started/general-information-concerning-patents# 
heading-31 [https://perma.cc/V38L-65QB].  See also supra note 54 and accompanying text 
(explaining the starting and ending dates of patent terms in further detail). 
99 § 163.  The rights conveyed by a plant patent are limited to a single plant or genome.  
General Information about 35 U.S.C. § 161 Plant Patents, supra note 57.  Thus, a sport or mutant 
of the patented plant does not infringe on the patent.  Id.  Furthermore, the Federal Circuit 
held in Imazio Nursery v. Dana Greenhouses that “the scope of a plant patent is the asexual 
progeny of the patented plant variety.”  69 F.3d 1560, 1568 (Fed. Cir. 1995).  Therefore, to 
establish infringement, the patentee must show that the accused infringer asexually 
reproduced the progeny of the “original patented parent plant.”  MUELLER, supra note 46, at 
289. 
100 See General Information about 35 U.S.C. § 161 Plant Patents, supra note 57 (noting the 
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In sum, there are three types of patents:  utility patents, design patents, 
and plant patents.101  To be protected by a patent, an invention or 
discovery must satisfy four requirements:  it must encompass patent-
eligible subject matter, and it must be new, useful, and non-obvious.102  
The USPTO evaluates whether an invention meets these requirements 
during the patent application process, known as the patent prosecution 
process.103 
2. Patent Prosecution Process 
The process of preparing and filing a patent application, and 
thereafter interacting with the patent examiner to obtain the patent, is 
called patent prosecution.104  The interaction process between the 
applicant and the USPTO begins with the filing of an application.105  Once 
                                                
provisions of Title 35 relating to utility patents apply to plant patents and that plant patent 
applications “must also satisfy the general requirements of patentability”); Manual of Patent 
Examining Procedures § 1602 (Nov. 2015), http://www.uspto.gov/web/offices/ 
pac/mpep/s1602.html [https://perma.cc/R7TF-SFCW] (indicating the “rules relating to 
applications for patent for other inventions or discoveries are also applicable to applications 
for patents for plants except as otherwise provided”).  The subject matter of a plant patent is 
the new asexually reproduced variety.  General Information about 35 U.S.C § 161 Plant Patents, 
supra note 57.  Plant patent applications must also meet the novelty and non-obviousness 
requirements.  Id.  To satisfy the novelty requirement, a plant must “differ from known, 
related plants by at least one distinguishing characteristic, which is more than a difference 
caused by growing conditions or fertility levels, etc.”  Id. 
101 See GOLDSTEIN & REESE, supra note 48, at 418–19 (outlining the types of patents granted 
by the USPTO). 
102  See § 101 (listing patentable subject matter and providing for the utility requirement); 
§ 102 (setting forth the novelty requirement); § 103 (establishing the nonobviousness 
requirement). 
103 See MUELLER, supra note 46, at 42 (explaining what the patent prosecution process is and 
how it works); see also infra Part II.B.2 (describing in detail the patent prosecution process). 
104 See id. (defining prosecution as “the process of preparing and filing an application in 
the USPTO and thereafter interacting with the agency in order to obtain a U.S. patent”). 
105 See id. (asserting the prosecution process begins when the application is filed).  Two 
types of applications can be filed:  provisional and nonprovisional applications.  Id.  General 
Information Concerning Patents, supra note 98 (describing the requirements and different types 
of applications for a patent).  Nonprovisional applications are substantively examined by the 
USPTO, while provisional applications are not.  See MUELLER, supra note 46, at 43 (noting 
provisional applications are not substantively examined); General Information Concerning 
Patents, supra note 98 (stating provisional applications are not examined on their merits).  
Provisional applications became available on June 8, 1995 with the purpose of lowering the 
costs of first patent filings.  General Information Concerning Patents, supra note 98.  When 
submitting a provisional application, contrary to nonprovisional applications, an applicant 
is not required to submit claims or an oath of declaration.  Id.  The only requirement is a filing 
fee and a cover sheet indicating the application is provisional in nature.  Id.  After filing a 
provisional application, the applicant has up to twelve months to file a nonprovisional 
application.  Id.  The USPTO will deem the application abandoned if the applicant fails to file 
a nonprovisional application.  Id.  Filing a provisional application provides the applicant 
Valparaiso University Law Review, Vol. 51, No. 3 [2017], Art. 5
https://scholar.valpo.edu/vulr/vol51/iss3/5
2017] Patentability of Marijuana 671 
an application is accepted as complete, a USPTO examiner is assigned to 
the application.106 
First, the examiner reviews the content of the application and decides 
if it meets the requirements of 35 U.S.C § 111(a).107  Next, the examiner 
considers whether the invention claimed satisfies the various statutory 
requirements for patentability.108  Depending on the determinations made 
by the examiner, the examiner may allow all the claims of the application, 
reject all the claims, or allow some claims and reject others.109  If the 
examiner determines the application does not meet one or more of the 
requirements, the examiner will explain the reasons for his rejection of the 
claims in an office action.110  The applicant has up to six months from the 
mailing date on the office action to either amend the claims or to argue 
against the objections.111  Thereafter, the examiner reexamines the 
                                                
with the opportunity to establish an early effective filing date.  Id.  Meaning the applicant 
may rely on the filing date of the provisional application as the priority date for the invention 
claimed in the later filed nonprovisional application.  MUELLER, supra note 46, at 43.  Thus, 
in assessing the novelty and nonobviousness of the invention, the examiner is required to 
consider only prior art with effective dates earlier that the filling date of the provisional 
application.  Id.  Importantly, the patent, if granted, will expire twenty years from the filing 
date of the nonprovisional application—not twenty years from the filing date of the 
provisional application.  Id. at 44.  Hence, the twelve-month period between applications 
does not shorten the patent term.  Id. 
106 See Patent Process Overview, U.S. PAT. & TRADEMARK OFF. (Oct. 27, 2015), 
http://www.uspto.gov/patents-getting-started/patent-process-overview 
[https://perma.cc/4WMV-L5ZJ] (denoting an application is assigned for examination once 
it is accepted as complete).  If an application filed is incomplete, the applicant is notified and 
given an opportunity to complete the application.  Id.  If the applicant fails to complete the 
application within the specified period, the application is “returned or otherwise disposed 
of.”  Id. 
107 See id. (indicating the examiner reviews the content of the application to determine if it 
includes the requirements set forth in 35 U.S.C. § 111(a):  a specification, a drawing, and an 
oath or declaration); MUELLER, supra note 46, at 45 (explaining an examiner first determines 
if the application satisfies the disclosure and claiming requirements). 
108 See MUELLER, supra note 46, at 45 (specifying the examiner considers whether the 
invention is patentable subject matter, useful, new, and nonobvious). 
109 See id. (adding that, depending upon the determinations made by the examiner, he may 
allow certain claims and reject others, or allow all the claims or reject all the claims). 
110 See id. (noting the examiner conveys and explains all of his determinations to the 
applicant in an official document); Patent Process Overview, supra note 106 (“If the examiner 
does not think your application meets the requirements, the examiner will explain the 
reason(s).”).  This is known as the first office action.  MUELLER, supra note 46, at 46.  It takes 
approximately two years after filing the application to receive the first office action.  Id. 
111 See 35 U.S.C. § 132(a) (2012) (outlining an applicant’s options in response to a notice of 
rejection); see also MUELLER, supra note 46, at 46 (stating an applicant has a period of six 
months to respond to the first office action); Patent Process Overview, supra note 106 
(indicating the applicant has an opportunity to amend the claims or “argue against the 
examiner’s objections”).  If the applicant does not respond to the office action within the 
required time, the application is deemed abandoned.  Patient Process Overview, supra note 
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application and issues a second office action, which is known as the Final 
Action.112  In the response, the applicant must overcome all the 
objections.113  Nonetheless, if the Final Action rejects a claim for a second 
time or the applicant disagrees with the rejections, the applicant may 
appeal to the Patent Trial and Appeal Board (“PTAB”), file a request for 
continued examination (“RCE”), or file a “continuing application.”114  If at 
any time during the process the examiner determines the invention is 
entitled to a patent, the examiner will issue a Notice of Allowance.115  
Approximately three months after the applicant pays for an issuing fee, 
the USPTO will issue the patent.116 
C. Marijuana and Patent Law 
There are a wide variety of inventions the marijuana industry could 
seek to protect under design, plant, or utility patents.  First, inventors 
could apply for design patents to protect the ornamental designs of items 
used in the marijuana industry.117  Second, inventors could apply for plant 
                                                
106.  Specifically, in the response, the applicant may “traverse” the rejections or narrow the 
scope of the claims to overcome the rejection.  See id. (noting that when responding to the 
examiner’s rejections, the applicant can make arguments for patentability (“traverse”) to 
overcome the rejection or narrow the scope of the claims by amending them to avoid the 
prior art).  When the applicant attempts to traverse a rejection, the applicant submits 
evidence in support thereof.  Id.  The applicant may change the wording of the claims, add 
new claims, or amend the written description as long as no new matter is added.  Id. 
112 See MUELLER, supra note 46, at 47 (asserting the examiner reexamines the application 
once the applicant responds to the first office action).  Like the first office action, the Final 
Action can allow all the claims of the application, reject all the claims, or allow some of the 
claims and reject others.  Id. 
113 See Patent Process Overview, supra note 106 (providing an applicant has to overcome all 
of the examiner’s rejections in his response to a Final Action).  This time, however, the 
applicant cannot argue against the objections.  See MUELLER, supra note 46, at 47 (indicating 
an applicant cannot argue the rejections asserted in a Final Action). 
114 See § 134 (“An applicant for a patent, any of whose claims has been twice rejected, may 
appeal from the decision of the primary examiner to the Patent Trial and Appeal Board, 
having once paid the fee for such appeal.”); MUELLER, supra note 46, at 47 (stating that after 
the Final Action, an applicant can request for continued examination or file a second or 
“continuing” application).  Requests for continued examinations (“RCEs”) and “continuing” 
applications are beyond the scope of this Note; however, see MUELLER, supra note 46, at 47–
48 for a detailed explanation of these options. 
115 See § 151 (noting the Office issues a Notice of Allowance when the applicant is entitled 
to a patent); see also MUELLER, supra note 46, at 48 (“Whenever in the process the examiner 
determines that the applicant is entitled to a patent on some or all of the claims, he will send 
the applicant a Notice of Allowance so indicating.”). 
116 See MUELLER, supra note 46, at 48 (indicating the applicant must pay an issue fee within 
three months to obtain the patent). 
117 See Neil Juneja, Patent Law in the Marijuana Industry, MARIJUANA VENTURE (Nov. 20, 
2014), http://www.marijuanaventure.com/patent-law-marijuana-industry/ 
[https://perma.cc/Z8VA-8SZN] (noting bongs, vaporizers, packaging for edibles, and 
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patents to protect newly developed varieties of the marijuana plant, like 
the patent Holmes is requesting for his Otto II medical-grade marijuana 
strain.118  Third, inventors could seek utility patents having claims 
directed to either marijuana plants or marijuana-related technologies.119  
Marijuana plants themselves are also protectable under a utility patent.120 
There are two legality concerns surrounding patent applications 
claiming marijuana strains or marijuana-related inventions, relating to the 
use and subject matter of the invention.121  First, some of the inventions 
can be used only for illegal purposes under federal law.122  Specifically, 
inventions particularly designed to be used in association with marijuana, 
and that can only be used for such purpose, would only be useful for 
illegal purposes.123  Nonetheless, some of the inventions can be used 
                                                
marijuana-related glassware are among the products that could be protected under design 
patents). 
118 See Blevins, supra note 1 (telling Ben Holmes’s story and his desire to obtain a patent 
protecting his Otto II medical–grade marijuana strain which, if granted, would be the first 
marijuana plant patent); see also Victoria Slind-Flor, Roche, Marijuana, Bakken, MakeMyTrip:  
Intellectual Property, BLOOMBERG BUS. (Jan. 5, 2015), http://www.bloomberg.com/ 
news/articles/2015-01-05/roche-bakkken-fleetmanager-makemytrip-intellectual-property 
[https://perma.cc/4MQR-K84K] (noting a Colorado marijuana seed producer has applied 
for the first U.S. plant patent for marijuana). 
119 See Juneja, supra note 117 (providing that methods for breeding and producing specialty 
cannabis, software systems for managing cannabis crops, methods for infusing products 
with marijuana and the machines used in the process, methods of making edibles, and 
cannabis extraction devices are among the technologies that could be protected with a utility 
patent); see also Pat. App. No. 20150165030 (June 9, 2016), http://www.google.com/patents/ 
US20150165030 [https://perma.cc/289X-NABL] (describing an application for a “Method 
for Making and Storing Stable Cannabinoid Compositions and Method for Treatment Using 
Such Compositions”). 
120 See J.E.M. AG Supply, Inc. v. Pioneer Hi-Bred Int’l, Inc., 534 U.S. 124, 145 (2001) (holding 
both asexually and sexually reproduced plants are eligible for protection under utility 
patents); MUELLER, supra note 46, at 288 n.157 (noting plant-related inventions qualify as 
patentable subject matter under 35 U.S.C. § 101); General Information about 35 U.S.C. § 161 
Plant Patents, supra note 57 (asserting the USPTO accepts utility patent applications with 
claims to plants and seeds); Manual of Patent Examining Procedures § 2105, (Mar. 2014), 
https://www.uspto.gov/web/offices/pac/mpep/s2105.html [https://perma.cc/QYF4-
JRTQ] (indicating patentable subject matter under 35 U.S.C. § 101 includes plant breeds). 
121 See Matthew Sean Tucker, Useful Patent for Some Legitimate Purpose, TUCKER IP (Dec. 6, 
2013), http://www.tuckeriplaw.com/useful-patent/ [https://perma.cc/7D93-LDZR] (“If 
the invention claimed by the patent application can only be used for an illegal purpose under 
federal law, then the invention would likely be interpreted by the patent office [as] lacking 
utility, i.e., lacking usefulness, and therefore be rejected.”); see also Davis, supra note 8 
(explaining some lawyers think the USPTO is “unlikely to allow patent protection for a 
substance the federal government has deemed illegal”). 
122 See Blevins, supra note 1 (reporting the USPTO has rejected cannabis-related patents 
because the invention has no useful purposes since its use violates federal law); see also 
Tucker, supra note 121 (commenting a “crafty” patent attorney should be able to obtain a 
marijuana-related patent if she describes and claims non-illegal uses for the invention). 
123 See Tucker, supra note 121 (“[A] machine specifically designed—and having only one 
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outside the marijuana industry.124  Second, the subject matter of some 
marijuana-related inventions is illegal; meaning the invention itself is 
illegal.125  Finally, in some cases, the application claims illegal subject 
matter and practicing the invention is illegal.126 
Interestingly, the USPTO has already issued patents that involve 
chemicals isolated from the marijuana plant, as well as patents covering 
smoking paraphernalia.127  This suggests the USPTO is willing to issue 
patents “around the edges of marijuana.”128  However, attorneys argue 
that the USPTO will not be as willing to grant a patent claiming the plant 
itself or a patent protecting an invention that can only be used in 
relationship with marijuana.129  Therefore, plant patents and utility 
                                                
purpose—to cultivate [a] new [marijuana] strain would not be patentable.”).  For example, a 
method of cultivating a specific marijuana strain that would only work for cultivating that 
specific marijuana strain is only useful for the illegal activity of growing marijuana. 
124 See Juneja, supra note 117 (stating for example, bongs and vaporizers can be used with 
legal products, such as oils or tobacco). 
125 See Davis, supra note 8 (stating attorneys believe the USPTO will not allow patents 
protecting a substance that is illegal under federal law); Forest, Cannabis:  Patently Useless?, 
DRUG L. & POL’Y (Feb. 25, 2015), https://druglawandpolicy.wordpress.com/2015/02/25/ 
cannabis-patently-useless/ [https://perma.cc/GA3G-NPR2] (questioning whether the 
USPTO would be willing to grant patents on something that is illegal).  One example is a 
patent claiming a strain of cannabis.  See Blevins, supra note 1 (reporting the USPTO has 
rejected cannabis-related patents because marijuana is illegal); Davis, supra note 8 (quoting 
attorney David Resnick from Nixon Peabody LLP, who thinks the USPTO will say:  “[T]his 
is illegal under federal law, and we’re not going to promote it . . . .”).  The marijuana strain, 
the subject matter of the invention, is in and of itself illegal.  See supra note 8 and 
accompanying text (explaining marijuana is a Schedule I substance, and thus, 
manufacturing, distributing, dispensing, or possessing marijuana is illegal).  Another 
example is a method for breeding specialty cannabis, since the subject matter of the 
invention, breeding cannabis, is illegal.  See id. (noting it is illegal to manufacture marijuana). 
126 See Tucker, supra note 121 (explaining a machine specifically designed to cultivate 
marijuana would not be patentable).  An application claiming a method for cultivating a 
specific marijuana strain that would only work for cultivating that specific marijuana strain, 
would be useful for illegal purposes and its subject matter—cultivating marijuana strains—
would also be illegal.  See 21 U.S.C. § 841 (2012) (exemplifying it is illegal to manufacture and 
posses marijuana). 




(listing all the marijuana-related patent applications pending at the USPTO); Patents Related 
to Cannabis, CANNABIS RES. A TO Z (Oct. 28, 2015), http://www.calgarycmmc.com/ 
cannabispatents.htm [https://perma.cc/QF2S-LQEP] (listing patents related to cannabis 
that have issued between 2000–2013). 
128 Davis, supra note 8.  For example, the office might be willing to grant a patent on a 
software system for managing marijuana crops.  Id. 
129 See supra note 8 and accompanying text (suggesting the USPTO would not be willing to 
grant patents on inventions without any legal uses). 
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patents with claims directed to the plant “face [the] tough[est] road at [the] 
USPTO.”130 
III.  ANALYSIS 
Recently, the USPTO started receiving applications for patents 
seeking to protect new strains of marijuana and marijuana-related 
technologies.131  These applications have followed state legislative 
decisions legalizing marijuana for medical and recreational use.132  
However, marijuana remains illegal under federal law, and thus, many 
attorneys argue it is unlikely the USPTO will issue patents protecting 
marijuana-related inventions.133 
This Part of the Note analyzes the patentable utility of marijuana-
related inventions and suggests illegality should not affect the patentable 
utility of an invention.134  First, Part III.A examines the grounds of rejection 
that the USPTO could assert to deny marijuana-related patent applications 
for lack of patentable utility based on the drug’s classification as an illegal 
substance under federal law.135  Second, Part III.B analyzes case law to 
determine whether there is a sufficient legal basis for a rejection for lack 
                                                
130 See Davis, supra note 8 (discussing why marijuana plant patents “face [a] tough road at 
[the] USPTO”). 
131 See Blevins, supra note 1 (telling Ben Holmes’s story and describing his plant patent 
application for Otto II, a medical-grade marijuana strain); Davis, supra note 8 (indicating the 
USPTO has received patent applications seeking to protect new types of marijuana plants); 
Pat. App. No. 20150165030, supra note 119 (claiming a “Method for Making and Storing 
Stable Cannabinoid Compositions and Method for Treatment Using Such Compositions”); 
Patent Application Full Text and Image Database, supra note 127 (providing a list of all the 
marijuana-related patent applications pending before the USPTO). 
132 See Davis, supra note 8 (noting the USPTO started receiving patent applications relating 
to marijuana plants after Colorado and Washington legalized the recreational use of 
marijuana); see generally State Medical Marijuana Laws, supra note 6 (reporting a total of 
twenty-three states and the District of Columbia and Guam have legalized the use of 
marijuana for medical use); Todd Garvey & Brian T. Yeh, State Legalization of Recreational 
Marijuana:  Selected Legal Issues, CONG. RES. SERV. (Jan. 13, 2014), 
http://www.fas.org/sgp/crs/misc/R43034.pdf [https://perma.cc/DT32-YESK] (stating 
Colorado and Washington became the first states to legalize marijuana for recreational use). 
133 See Davis, supra note 8 (citing intellectual property attorneys that argue the USPTO will 
not issue patents protecting an illegal substance, including David Resnick of Nixon Peabody 
LLP, John Dragseth of Fish & Richardson PC, and Douglas Sorocco of Dunlap Codding).  But 
see id. (noting other attorneys have pointed out that “simply because something is illegal 
does not make it ineligible for a patent and that patents on marijuana strains may be 
permissible”). 
134 See infra Part III.A–B (evaluating the possible grounds of rejection the USPTO could 
potentially assert in denying marijuana-related patent applications and the legal basis for 
these grounds). 
135 See infra Part III.A (considering the arguments the USPTO could assert to deny 
marijuana-related patent applications). 
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of patentable utility based on an invention’s illegality.136  Next, Part III.C 
applies the legal basis evaluated in Part III.B to marijuana-related patent 
applications to determine whether they have patentable utility.137  Last, 
Part III.D proposes even though the USPTO may have sufficient legal 
basis to reject marijuana-related inventions for lack of utility based on 
marijuana’s classification as an illegal substance, illegality should not play 
a role in patent law.138 
A. Grounds of Rejection the USPTO Could Assert to Deny Marijuana-Related 
Patent Applications 
The USPTO could potentially deny marijuana-related patent 
applications for failure to satisfy any of the patentability requirements:  
patent-eligible subject matter, novelty, utility, and non-obviousness.139  
However, this Note only focuses on grounds of rejection for lack of 
patentable utility based on marijuana’s status as a controlled substance 
under federal law.140  Under In re Fisher, an invention must provide a 
significant, presently available, well-defined, and particular benefit to the 
public to satisfy the utility requirement.141  Accordingly, the USPTO could 
assert that marijuana-related inventions lack utility because they provide 
no benefit to the public.142  In making this argument, the USPTO would 
                                                
136 See infra Part III.B (examining the legal basis for the arguments the USPTO could assert 
to deny marijuana-related patent applications). 
137 See infra Part III.C (analyzing the role of illegality and morality in patent law). 
138 See infra Part III.D (concluding illegality and morality do not and should not play a role 
in patent law). 
139 See supra note 110 and accompanying text (indicating a patent application can be denied 
for failure to satisfy any of the patentability requirements). 
140 See infra Part III.A (discussing grounds of rejection for failure to satisfy the utility 
requirement).  Historically, immoral patents were invalidated for lack of patentable utility 
pursuant to the moral utility doctrine.  See supra note 78 and accompanying text (discussing 
the moral utility doctrine case law). 
141 421 F.3d 1365, 1371 (Fed. Cir. 2005) (defining utility in terms of substantial and specific 
utility); see also Brenner v. Manson, 383 U.S. 519, 534 (1966) (“The basic quid pro quo 
contemplated by the Constitution and the Congress for granting a patent monopoly is the 
benefit derived by the public from an invention with substantial utility.”) (emphasis added).  
Douglas J. Sorocco, a director and shareholder at Dunlap Codding, also suggests marijuana-
related applications “will be highly scrutinized as to the scope and quality of disclosure and 
many marijuana companies may find that the patent office will judge their applications 
scientifically inadequate . . . .”  See Ciccatelli, supra note 7 (interviewing Sorocco regarding 
the patentability of marijuana plants). 
142 See supra Part II.B.2 (providing an overview of the patent prosecution process and 
explaining that a patent examiner will determine whether the patent application satisfies all 
the patentability requirements, including the utility requirement); see generally Tucker, supra 
note 121 (“If the invention claimed by the patent application can only be used for an illegal 
purpose under federal law, then the invention would likely be interpreted by the patent 
office as lacking utility . . . .”); Davis, supra note 8 (noting the USPTO could cite the drug’s 
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rely on the federal government’s classification of marijuana as an illegal 
substance and contend the public can derive no benefit from the invention 
because either the invention itself is illegal or practicing the invention 
would be illegal.143 
However, an invention only needs to have one legitimate use to satisfy 
the utility requirement.144  To counter the USPTO’s argument, an applicant 
could argue that the invention satisfies the utility requirement because 
using the invention would be legal in the states that have legalized 
marijuana; therefore, the invention would have at least one legitimate 
use.145  The USPTO would have two rebuttal arguments.  First, the USPTO 
could point out federal law trumps state law, and thus, in the Office’s eyes, 
marijuana-related inventions are illegal and can only be used for 
                                                
classification as illegal to reject an application for a marijuana-related patent). 
143 See supra Part II.B.2 (indicating that when an examiner determines a patent application 
fails one of the statutory requirements for patentability, the examiner will explain the reasons 
for such failure in an Office Action); see also supra note 121 and accompanying text (explaining 
why marijuana related inventions could serve illegal purposes).  For example, if the 
application relates to a technology that will be used in association with marijuana, such as a 
method for breeding and producing specialty cannabis, the USPTO would claim the 
invention provides no benefit to the public, and thus, lacks utility because the invention will 
be used for illegal purposes.  See 21 U.S.C. § 841 (2012) (criminalizing the possession and 
manufacturing of marijuana).  On the other hand, if the application is either a plant patent 
application or a utility application with claims directed to a plant, for example, a method for 
using a certain amount of cannabinoid to treat a disease, the USPTO would argue the 
invention provides no benefit to the public, and thus, lacks utility because the invention itself 
is illegal.  See § 812 (listing marijuana as a controlled substance).  The invention itself would 
be illegal because manufacturing or possessing “any material, compound, mixture, or 
preparation, which contains any quantity of [marijuana], or which contains any of [its] salts, 
isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of 
isomers is possible,” is unlawful.  §§ 812, 841.  Furthermore, for applications of the latter type 
that specifically claim a medical benefit, the USPTO would have an even stronger argument 
because marijuana’s classification under federal law as a Schedule I substance is made on a 
determination that it has “no currently accepted medical use.”  § 812.  Accordingly, the utility 
claimed by the applicant would be non-existent in the eyes of the USPTO, a federal agency.  
But see Davis, supra note 8 (noting attorneys have pointed out “simply because something is 
illegal doesn’t make it ineligible for a patent and that patents on marijuana strains may be 
permissible”). 
144 See Juicy Whip, Inc. v. Orange Bang, Inc., 185 F.3d 1364, 1366 (Fed. Cir. 1999) (“An 
invention is ‘useful’ under Section 101 if it is capable of providing some identifiable 
benefit.”); Fuller v. Berger, 120 F. 274, 275 (7th Cir. 1903) (“[E]verything [is] useful within the 
meaning of the law, if it is used (or is designed and adapted to be used) to accomplish a good 
result, though in fact it is oftener used (or is as well or even better adapted to be used) to 
accomplish a bad one . . . .”); see also Smith, supra note 75 (explaining that following the 
Seventh Circuit’s decision in Fuller v. Berger, courts would find that an invention satisfies the 
utility requirement if the device has legal uses). 
145 See NAT’L CONF. OF ST. LEGIS., supra note 6 (noting a total of twenty-three states and the 
District of Columbia and Guam have legalized the use of marijuana for medical use). 
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illegitimate purposes.146  Second, even if federal law did not trump state 
law in this case, the rights conveyed by a patent are established under 
federal law.147  Accordingly, the USPTO could argue it has no choice but 
to accept Congress’s determination that marijuana has no recognized 
benefit to the public and no legitimate purpose or use, so long as 
marijuana remains a Schedule I substance under federal law.148 
Even though the USPTO’s contentions sound persuasive, they are 
entirely hypothetical because neither the USPTO nor courts have had to 
determine whether an invention lacks patentable utility because its subject 
matter or its use is illegal under federal law while legal under state laws.149  
Accordingly, Part III.B examines existing case law to determine whether 
the USPTO or courts would have sufficient legal basis for denying 
applications because an invention lacks legal utility.150 
B. What Is the Legal Basis for Denying or Invalidating Patents for Lack of 
Moral or Legal Utility? 
Neither courts nor the USPTO have had to determine whether an 
invention lacks patentable utility because its subject matter and/or its use 
is illegal under federal law while legal under state laws.151  Accordingly, 
                                                
146 See Blevins, supra note 1 (“[F]ederal law trumps state law.”). 
147 See § 1338(a) (granting district courts original jurisdiction over civil actions “arising 
under any Act of Congress relating to patents” and denying state courts jurisdiction over 
claims for relief “arising under any Act of Congress relating to patents”); see also Margo A. 
Bagley, The New Invention Creation Activity Boundary in Patent Law, 51 W. & MARY 577, 606 
(2009) (“The right to exclude granted to a patentee is a right granted under the federal patent 
laws.”). 
148 See Davis, supra note 8 (noting the USPTO could “expressly cite the classification of the 
drug as illegal” to reject an application for a patent on the marijuana plant). 
149 See id. (“[T]here has never been a precisely analogous situation where a substance is 
legal in some states, but still technically illegal nationwide.”); see also Smith, supra note 75 
(noting federal courts have never addressed what effect, if any, outright illegality or banning 
of the subject matter of an invention by Congress would have on the determination of 
patentable utility); infra Part III.A.1–2 (discussing the possible legal basis the USPTO could 
rely on to reject patents on illegal subject matter and explaining how the cases are not on 
point).  According to a Vice News article, “[a] spokesperson for the US Patent and Trade 
Office confirmed that officials are now accepting and processing patent applications for 
individual varieties of cannabis, along with innovative medical uses for the plant and other 
associated inventions.”  Walters, supra note 1.  The article further indicated the spokesperson 
noted “no special statutory requirements or restrictions applied to marijuana plants.”  Id. 
150 See infra Part III.B.1 (evaluating the legal grounds for a rejection for lack of legal utility). 
151 See supra note 85 and accompanying text (noting uncertainties regarding illegality and 
patentable utility); see also In re Fisher, 421 F.3d 1365, 1371 (Fed. Cir. 2005) (specifying that 
under the utility standards set forth in Brenner, specific and substantial utility refers to a 
significant, presently available, particular, and well-defined benefit to the public, but 
providing no guidance on what should be considered in determining if an invention 
provides a benefit to the public). 
Valparaiso University Law Review, Vol. 51, No. 3 [2017], Art. 5
https://scholar.valpo.edu/vulr/vol51/iss3/5
2017] Patentability of Marijuana 679 
there is no federal court precedent directly applicable to this rejection.152  
Nonetheless, some of the cases on the moral utility doctrine’s application 
to gambling devices provide important insight as to what would be the 
effect of a declaration of illegality by Congress on the evaluation of 
patentable utility.153  Consequently, this Part examines relevant moral 
                                                
152 See Manual of Patent Examining Procedures § 2107.01, supra note 90 (indicating patentable 
utility is analyzed under the principles established in In re Fisher, without mentioning 
whether morality or illegality has to be considered when determining the invention’s benefit 
to the public); Smith, supra note 75, at 173 (noting that the effect of illegality on an evaluation 
of patentable utility is unknown). 
153 See supra notes 86–90 and accompanying text (discussing Fuller, Whistler, and Juicy Whip, 
three moral utility doctrine cases that allude to what would be the effect of illegality on the 
patentability of an invention).  There is no analysis of the grounds of rejection under the 
moral utility doctrine because it is assumed the doctrine is dead and courts and the USPTO 
are not willing to revive the doctrine, as evidenced by the USPTO’s reluctance to apply the 
doctrine when it had the opportunity, and the Manual of Patent Examining Procedure’s 
(“MPEP’s”) adherence to In re Fisher’s definition of patentable utility.  See supra note 84 and 
accompanying text (outlining scholarly articles discussing why the moral utility doctrine is 
no longer good law).  Starting in the late 1990s, the USPTO and the courts had several 
opportunities to deny or invalidate patents on controversial inventions by invoking the 
moral utility doctrine.  Smith, supra note 75.  The first opportunity arose in 1998 when an 
inventor filed an application involving “chimeric embryos that contained both human and 
nonhuman cells.”  Id.  The filing of the patent application attracted national media attention 
and “focused on the moral issue implicated by the[] proposed human-animal hybrids.”  
Keay, supra note 78.  While the USPTO initially responded by issuing a press release 
indicating human-animal chimeras were not patentable because, “among other things, they 
would fail to meet the public policy and morality aspects of the utility requirement,” the 
Office later retracted its stance.  Smith, supra note 75.  Instead, the Office rejected the 
application on the ground that it constituted non-eligible subject matter.  Keay, supra note 
78; Smith, supra note 75.  The human-animal chimera patent application was followed by 
countless controversial applications in the field of biotechnology that included methods for 
cloning, embryos containing both human and nonhuman cells, and a variety of gene patents.  
See Smith, supra note 75 (discussing the controversies with human cloning patent 
applications); Keay, supra note 78 (analyzing controversial applications in the field of 
biotechnology).  In rejecting or granting these applications, the USPTO made no reference to 
morality.  See Smith, supra note 75 (noting that the USPTO rejections were on grounds of 
ineligible subject matter); Keay, supra note 78 (describing the USPTO’s rejections under 
subject matter eligibility grounds).  The fact that the Office had several opportunities to re-
consider morality in patentable utility, but did not, demonstrates that the office is not 
comfortable with rejecting patents on such grounds.  See Smith, supra note 75 (noting the 
USPTO is not comfortable rejecting patents on a moral basis).  Further, the MPEP, which 
outlines the laws and regulations followed by the USPTO when examining patent 
applications, makes no reference to morality or Justice Story’s definition of utility.  See 
Manual of Patent Examining Procedures § 2107, supra note 90 (indicating the MPEP does not 
“constitute substantive rulemaking and hence do[es] not have the force and effect of the 
law”); In re Fisher, 421 F.3d at 1372 (noting courts are willing to give the MPEP “judicial 
notice” to the extent it does not conflict with the Patent Act); MUELLER, supra note 46, at 34 
(explaining that the MPEP is very useful in understanding the way the USPTO approaches 
patentable utility).  Most likely, if the USPTO would have wanted to leave the door open to 
the application of the moral utility doctrine in the future, or for considering public morals 
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utility doctrine precedent to determine what would be the legal basis for 
rejections based on a declaration of illegality by Congress.154 
The moral utility doctrine was historically used to invalidate 
gambling and deceptive inventions.155  When it came to patents covering 
gambling devices, while courts referred to the immorality of gambling to 
invalidate the patents, the courts’ reasoning was closely related to strong 
anti-gambling state laws of the time.156  Thus, these cases were concerned 
with illegality as well as morality.157 
The first important insight on a possible rejection for lack of legal 
utility is provided in Fuller.158  Fuller explained that state laws preventing 
the patentee from practicing his invention did not affect his right to 
exclude others from using the invention where legal.159  The court’s 
conclusion appears to suggest that state laws affecting the legality of use 
of an invention should not affect the patentability of the invention.160  
                                                
when determining patentable utility, it would have included it in the Guidelines. 
154 See infra Part III.B (determining that a federal declaration of illegality would affect 
patentable utility in limited circumstances). 
155 See supra note 78 and accompanying text (examining cases applying the moral utility 
doctrine to gambling and deceptive devices and tracing the evolution of the doctrine). 
156 See Keay, supra note 78 (“Moral opposition to gambling in the United States was highest 
around the same time courts were invalidating patents for gambling devices . . . and two 
strong waves of anti-gambling sentiment led to near prohibition of gambling activities” in 
the twentieth century); see generally, Roger Dunstan, History of Gambling in the United States 
(Oct. 30, 2015), http://www.library.ca.gov/crb/97/03/chapt2.html [https://perma.cc/ 
E3AA-2TLE] (examining the history of gambling in North America); George G. Fenich, A 
Chronology of (Legal) Gaming in the U.S., 30 GAMING RES. & REV. J. 65 
http://digitalscholarship.unlv.edu/cgi/viewcontent.cgi?article=1223&context=grrj 
[https://perma.cc/WKS6-TM2Q] (providing a timeline of the development of gaming in the 
U.S.); G. Robert Blakey & Harold A. Kurland, The Development of the Federal Law of Gambling, 
63 CORNELL 923, 927–58 (1978) (detailing the history of the evolution of federal gambling 
laws); see also Fuller v. Berger, 120 F. 274, 179–82 (7th Cir. 1903) (Grosscup, dissenting) 
(examining the morality of gambling). 
157 See Fuller, 120 F. at 179–282 (invalidating a gambling-related patent for want of utility 
based on laws prohibiting gambling and social perceptions that gambling was immoral). 
158 See id. at 276 (holding that a bogus-coin detector used with gambling devices did not 
lack patentable utility simply because it could be used with gambling devices).  The court 
indicated courts should not void patents for want of utility if the defendant proves the 
invention has been used to accomplish bad results if the court can be convinced the invention 
can be used to achieve positive results.  Id. 
159 See id. at 279 (“[A] state law which prohibits the use of a certain article, which is 
patented, is not in derogation of the inventor’s grant under the patent law.”).  The court 
rejected the accused infringer’s argument that the court should deny an injunction because 
the invention could only be used for illegal purposes under state law.  Id.  The court noted 
that a device had the requisite utility if it could be used for a good purpose, even if it is most 
often used to accomplish negative results.  Id. at 275.  Fuller provided several examples of 
devices that have positive and negative purposes, including the colt revolver, steam engines, 
dynamos, and electric railroads.  Fuller, 120 F. at 275–76. 
160 See id. (“[T]he state law operated wholly upon the inventor’s natural right to the use of 
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However, at the time Fuller was decided, gambling, although highly 
regulated under federal law, was only illegal under most state laws.161  
Thus, Fuller’s conclusion, when analyzed in context, is arguably limited to 
the patentability of inventions that have illegal uses under state laws, but 
permitted uses under federal law.162  Further, the laws at issue in Fuller 
concern only the legality of use of an invention.163  Fuller’s holding is, 
therefore, only informative on the patentability of inventions that have 
illegal uses and sheds no light on the patentability of inventions whose 
subject matter is illegal in some states, but legal in others.164  Thus, while 
Fuller’s holding is instructive on the patentability of an invention that can 
be used for illegal purposes under state laws, it is impossible to discern 
whether the court’s opinion would change if federal laws also made the 
use illegal.165 
Nonetheless, Whistler Corporation v. Autotronics, Inc. is informative on 
the effect a federal ban could have on a determination of patentable 
utility.166  In Whistler, the court held that a radar signal detector primarily 
used to circumvent the law was patentable, instructing, “[u]nless and until 
detectors are banned outright, or Congress acts to withdraw patent 
protection for them, radar detector patentees are entitled to the protection 
of the patent laws.”167  Whistler’s reference to an “outright ban” on the 
subject matter of the invention, the detector, suggests that an invention 
                                                
his property, and not at all upon the franchise which the patent grants, which consists 
altogether in the right to exclude.”) (emphasis added).  Fuller reasoned that state laws that 
affected the use of the patented article did not affect the rights granted on the patentee 
because patent law grants exclusionary rights.  Id. 
161 See supra note 156 and accompanying text (examining the state of gambling laws at the 
time the moral utility doctrine was used to invalidate patents covering gambling devices). 
162 See supra note 8 and accompanying text (explaining medical and recreational marijuana 
is legal in some states but is illegal under federal law, and because patent rights are 
established under federal law, it is unclear whether the USPTO will issue patents protecting 
marijuana plants and marijuana-related inventions).  At the time Fuller was decided, all 
states but New Mexico had prohibited gambling.  Fuller, 120 F. at 279.  Nonetheless, the 
federal government had not banned gambling, it simply regulated it.  Supra note 156 and 
accompanying text. 
163 See Fuller, 120 F. at 279 (noting that gambling laws affected the inventor’s right to use 
the invention and not the right to exclude others). 
164 See id. at 279–80 (examining the patentability of a gambling device at a time in history 
where gambling was illegal under state laws but permitted under federal law). 
165 See id. at 276 (holding that an invention that could be used in association with gambling 
devices did not lack patentable utility despite state laws banning gambling). 
166 See No. CA3–85–2573–D, 1988 WL 212501, at *1 (N.D. Tex. July 28, 1988) (finding that 
whether a device used to circumvent the law is patentable is a matter “for the legislatures of 
the states, or for the Congress, to decide[,]” not the court). 
167 See id. (noting only two states have prohibited such devices). 
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would lack patentable utility if its subject matter were illegal under federal 
law.168 
Whistler is also informative on whether the patentable utility of an 
invention would be affected if the invention is useful for purposes banned 
by Congress but the invention’s subject matter is not banned.169  It may be 
inferred, from the court’s reasoning when scrutinizing the court’s choice 
of words in light of the alleged infringer’s arguments, that the 
patentability of an invention is not affected by a federal or state ban on the 
use of the invention, so long as the subject matter of the invention is not 
federally banned.  Notice the alleged infringer argued that the radar was 
not patentable because it was used for an illegal purpose—to circumvent 
the law.170  The alleged infringer did not argue the invention itself was 
illegal—only its application.171  Yet, the court’s reasoning focused on a ban 
by Congress on the subject matter of the invention and not its application.172  
This suggests the court is not concerned with the legality of an invention’s 
applications but with the legality of the invention’s subject matter.173  
Thus, it appears the court would reason that an invention has patentable 
utility even if it is useful for purposes banned by Congress, as long as its 
                                                
168 See id. (explaining that even though two states have prohibited the use of radar signal 
detectors, the court cannot withdraw patent protection from such devices until Congress 
does so because that is a matter for the legislatures of the states or for Congress to decide). 
169 See id. (concluding a radar detector used primarily and exclusively for the illegal 
purpose of circumventing the law was patentable until Congress banned these devices). 
170 See id. (commenting in response to the defendant’s defense of lack of utility, the court 
below noted the “incongruity” of the plaintiff’s request to protect a device used to 
circumvent the law).  Plaintiff presented evidence that the detectors had alternative legal 
uses, but the court decided that the “primary and almost exclusive purpose” of the radar 
detectors was to “circumvent law enforcement attempts to detect and apprehend those who 
violate the law.”  Id. 
171 See Whistler Corp., 1988 WL 212501, at *1 (rejecting the infringer’s argument that the 
invention’s use—circumventing the law—was illegal and therefore, the radar lacked 
patentable utility). The infringer, however, did not argue that the invention, the radar, was 
illegal.  Id. 
172 See id. (reasoning a ban on the detectors, not the use of the detectors, would prevent 
them from being patentable).  The court stated that radar detectors are patentable “unless 
and until detectors are banned outright,” instead of indicating that they are unpatentable 
unless and until the use of detectors is banned outright.  Id.  (emphasis added). 
173 See id. (concluding that signal radar detectors are patentable, despite being useful 
primarily for illegal purposes, until Congress bans detectors or withdraws patents 
protection).  This conclusion is consistent with the Federal Circuit’s statements in Juicy Whip 
indicating the utility doctrine was not in place for the USPTO or courts to serve as arbiters 
of what inventions are designed to serve illegal purposes.  Juicy Whip, Inc. v. Orange Bang, 
185 F.3d 1364, 1368 (Fed. Cir. 1999).  The court concluded it is Congress’s job to determine 
whether a particular invention should not be patentable.  Id.  Similarly, the court in Whistler 
questioned the possibility of “being required to referee a [public interest] contest among 
entities that manufacture and sell products.”  Whistler Corp., 1988 WL 212501, at *1. 
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subject matter remains legal.174  It also appears the court would not change 
its reasoning if the invention could only be used for illegal purposes under 
federal law.175  This can also be inferred from the specific words used in 
the court’s reasoning, since it noted the primary and almost exclusive use 
of the detector was to circumvent the law, but it nonetheless deemed the 
device patentable.176 
Overall, Fuller is informative of how state laws concerning the use of 
an invention would affect a determination of patentable utility.177  
Specifically, under Fuller, state laws prohibiting the use of an invention 
should not affect the patentability of an invention.178  Fuller, however, 
sheds no light on whether an invention would be patentable if federal laws 
also prohibited the use of the invention.179  Whistler, however, is 
specifically revealing of how a congressional ban on the subject matter of 
                                                
174 See supra note 171 and accompanying text (explaining that in Whistler, while the accused 
infringer argued the invention lacked patentable utility because it was useful for the illegal 
purpose of circumventing the law, the court nonetheless ruled the invention was useful 
because its subject matter, a radar detector, was not illegal under federal law). 
175 See Whistler Corp., 1988 WL 212501, at *1 (concluding that a signal radar detector whose 
“primary and almost exclusive purpose” is to circumvent the law has the requisite patentable 
utility because the subject matter of the invention, the radar, is not illegal under federal law). 
176 See id. (holding that despite the fact the “primary and almost exclusive purpose” of the 
radar was to illegally circumvent the law, the radar was patentable unless and until Congress 
made a determination to the contrary).  This is consistent with Fuller and Juicy Whip.  In Fuller, 
the court noted that an invention does not lack patentable utility if the invention is used for 
vicious purposes, as long as the invention is capable of good uses, even if never used for such 
good purposes.  See Fuller, 120 F. at 279 (“[E]verything [is] useful within the meaning of the 
law, if it is used (or designed and adapted to be used) to accomplish a good result, though 
in fact it is oftener used (or is as well or even better adapted to be used) to accomplish a bad 
[result].”).  In Juicy Whip, the court explained that an invention having the capacity to fool 
the public did not lack utility unless Congress declared that particular type of invention 
unpatentable.  See Juicy Whip, 185 F.3d at 1368 (“Congress is free to declare particular types 
of inventions unpatentable for a variety of reasons, including deceptiveness.  Until such time 
as Congress does so, however, we find no basis in section 101 to hold that inventions can be 
ruled unpatentable for lack of utility simply because they have the capacity to fool some 
members of the public.”). 
177 See supra notes 159, 163 and accompanying text (explaining that Fuller’s holding 
suggests state laws concerning the use of an invention do not affect the patentability of the 
invention).  In Fuller, the court held that a coin detector used with gambling devices did not 
lack patentable utility simply because it could be used for illegal purposes under state law.  
120 F. at 276. 
178 See Fuller, 120 F. at 279 (holding that state laws affecting the use of the invention did not 
affect the right granted by a patent to exclude others from using the invention). 
179 See id. (discussing the effect state laws—and not federal laws—prohibiting the use of an 
invention would have on a patentee’s right to use the invention, but not his right to exclude 
others).  Fuller does not address whether an invention would be patentable even if federal 
laws, whether in contradiction or not with state laws, prohibited the use of the invention.  Id. 
at 276, 279–80.  It also does not address whether state or federal laws banning the subject 
matter of an invention would prevent the invention from being patentable.  Id. 
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an invention would affect the determination of patentable utility.180  
Particularly, under Whistler, an invention would lack patentable utility if 
its subject matter were illegal under federal law (“outright” ban by 
Congress).181  Whistler also suggests that an invention would not lack 
utility if it were useful for purposes banned by Congress, as long as the 
subject matter of the invention remains legal.182 
As such, Fuller and Whistler suggest the USPTO may have sufficient 
legal basis to reject patent applications for lack of legal utility under 
limited circumstances.183  Next, these legal bases are applied to marijuana-
related innovations next, to determine whether marijuana-related 
inventions lack patentable utility.184 
C. Are Marijuana Plants and Marijuana-Related Inventions Patentable under 
Fuller and Whistler? 
The USPTO could hypothetically deny marijuana plant patent 
applications or marijuana-related patent applications for lack of legal 
utility.185  Part III.B indicated that based on Fuller and Whistler, the USPTO 
could reject patent applications for lack of legal utility under limited 
circumstances.186  This Part of this Note discusses the application of the 
legal bases examined in Part III.B to determine whether marijuana-related 
inventions are not patentable for lack of legal utility.187  Even though some 
marijuana inventions might not be patentable under Fuller and Whistler 
because of marijuana’s status as a controlled substance under federal law, 
this Note recommends that illegality should not affect a determination of 
patentable utility.188 
                                                
180 See 1988 WL 212501, at *1 (holding that a signal radar detector used to circumvent the 
law was patentable until Congress decided to the contrary). 
181 See supra note 170 and accompanying text (concluding that under Whistler, an invention 
would not be patentable for lack of utility if a federal law prohibited the subject matter of the 
invention). 
182 See supra note 173 and accompanying text (explaining that the court’s reasoning focused 
on a ban by Congress on the subject matter of the invention and not its use as evidenced by 
the court’s choice of words in light of the infringer’s argument). 
183 See supra Part III.B (analyzing the moral utility doctrine cases of Fuller and Whistler to 
determine what would be the effect of a Congressional ban on the patentable utility of an 
invention). 
184 See infra Part III.C (applying the legal grounds outlined in Fuller and Whistler to 
marijuana-related inventions to determine whether they lack patentable utility). 
185 See supra Part III.A (describing the two possible grounds of rejection the USPTO could 
assert to deny marijuana-related patent applications). 
186 See supra Part III.B (evaluating the effect of a declaration of illegality by Congress on the 
evaluation of patentable utility). 
187 See infra Part III.C (determining the patentability of marijuana-related inventions under 
Fuller and Whistler). 
188 See infra Part III.D (suggesting that a court deciding on the patentability of marijuana 
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Pursuant to Fuller, state laws concerning the legality of the use of an 
invention do not affect the patentability of the invention.189  Thus, under 
Fuller, the fact that using marijuana is legal in some states while illegal in 
others would have no bearing on the patentable utility of marijuana-
related inventions.190  Nonetheless, Fuller provides no insight on whether 
federal laws regarding the use of an invention would affect the 
patentability of the invention.191  Fuller’s holding is arguably limited to the 
patentability of inventions where state laws prohibit the use of the 
invention but federal law allows it, whereas the issues surrounding the 
patentability of marijuana plants and marijuana-related inventions arise 
from contradictory state and federal laws.192  Therefore, it is impossible to 
discern whether marijuana strains and marijuana-related inventions have 
patentable utility under Fuller. 
Under Whistler, an invention lacks patentable utility if Congress has 
banned the invention’s subject matter.193  Thus, pursuant to Whistler, 
marijuana strains would always lack patentable utility and would not be 
protectable because Congress has banned its subject matter.194  Similarly, 
marijuana-related inventions whose subject matter is illegal would also 
lack patentable utility.195  Further, under Whistler, an invention has 
                                                
inventions should hold that such inventions do not lack patentable utility simply because 
marijuana is illegal under federal law). 
189 See supra notes 159, 163 and accompanying text (analyzing Fuller’s holding to determine 
whether precedent suggests what effect, if any, illegality should play in the determination of 
patentable utility and concluding the court was not concerned with state laws affecting the 
use of the invention). 
190 See supra note 160 and accompanying text (noting Fuller indicated state laws only affect 
a patentee’s natural right to use his invention but do not affect the rights afforded to him by 
his patent to exclude others from using his invention). 
191 See supra note 164 and accompanying text (examining Fuller’s holding in context with 
the historical background and noting that at the time Fuller was decided, state laws 
criminalized gambling, while federal law simply regulated gambling). 
192 See supra note 122 and accompanying text (explicating the legality concerns 
surrounding the patentability of marijuana strains and marijuana-related inventions). 
193 See No. CA3–85–2573–D, 1988 WL 212501, at *1 (N.D. Tex. July 28, 1988) (“Unless and 
until detectors are banned outright, or Congress acts to withdraw patent protection for them, 
radar detectors patentees are entitled to the protection of the patent laws.”). 
194 See 21 U.S.C. § 812 (2012) (criminalizing the possession, manufacture, and distribution 
of marijuana).  For example, the subject matter of Ben Holmes’s patent application claiming 
his Otto II strain is the cannabis strain itself.  This strain is illegal under federal law, and thus, 
under Whistler, the Otto II would lack patentable utility.  See § 812 (classifying marijuana as 
a Schedule I substance).  Similarly, the subject matter of a utility patent application with 
claims directed to the plant would be the plant itself.  For example, a patent application 
claiming a method for using Holmes’s Otto II strain to treat a disease would lack patentable 
utility because using medical marijuana is illegal under federal law.  See Marijuana Resource 
Center, supra note 36 (“[U]sing marijuana continues to be an offense under Federal law.”). 
195 See § 812 (listing marijuana as a prohibited substance under federal law).  For example, 
a patent application claiming a method for breeding specialty cannabis would not be 
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patentable utility irrespective of the invention being useful for illegal 
purposes, as long as its subject matter remains legal.196  Accordingly, 
marijuana-related inventions whose subject matter is legal would have 
patentable utility despite having illegal applications or its use resulting in 
illegal activity.197 
These results are consistent with the attorneys’ views discussed 
earlier—that marijuana-related patent applications that wholly claim 
illegal subject matter are not patentable, whereas applications claiming 
“around the edges of marijuana” should be patentable.198  These results 
are also supported by the fact that patents have already been granted on 
certain applications claiming marijuana-related inventions.199  Therefore, 
                                                
patentable because the subject matter of the invention, breeding specialty cannabis, is not 
legal under federal law.  See § 841 (providing it is illegal to manufacture and possess 
marijuana); see also Tucker, supra note 121 (indicating a machine specifically designed to 
cultivate marijuana would not be patentable).  As suggested by Tucker, an attorney could 
get away with claiming an invention related to illegal subject matter by describing the 
invention in broad terms so that it claims legal subject matter.  Tucker, supra note 121.  For 
example, the method for breeding cannabis could be claimed as simply a method for 
breeding specialty plants.  See id. (indicating “crafty” patent attorneys should be able to 
obtain a marijuana-related patent if they describe and claim non-illegal uses for the 
invention).  This would not be an option, however, for patents claiming only illegal subject 
matter, such as marijuana strains plant patent applications.  See id. (“If the invention claimed 
by the patent application can only be used for an illegal purpose under federal law, then the 
invention would likely be interpreted by the patent office [as] lacking utility, i.e. lacking 
usefulness, and therefore be rejected.”)  Therefore inventions particularly designed to be 
used in association with marijuana—and that can only be used for such purpose—would 
lack patentable utility.  Id. 
196 See 1988 WL 212501, at *1 (holding that whether a device used to circumvent the law is 
patentable is a matter “for the legislatures of the states, or for the Congress, to decide[,]” not 
the court). 
197 See supra note 170 and accompanying text (analyzing Whistler and concluding an 
invention would not be patentable if federal law prohibits the subject matter of the 
invention).  For example, a patent application claiming a method for infusing products with 
marijuana would be patentable if the method can be used to infuse products with other legal 
substances.  Tucker, supra note 121.  Notice the subject matter of the invention—the method 
for infusing products—is legal under both federal and state law.  However, the invention 
could serve illegal purposes if used to infuse products with marijuana.  See § 841 (possessing 
marijuana is illegal under federal law).  Other examples of inventions with illegal 
applications that would nonetheless be patentable include bongs and vaporizers.  See Juneja, 
supra note 117 (stating a vaporizer that can be used with legal oils should be patentable).  An 
example of an invention that would lack patentable utility because both its subject matter 
and use are illegal is a method of cultivating a specific marijuana strain that only works for 
cultivating that specific marijuana strain.  Id. 
198 See Davis, supra note 8 (quoting John Dragseth of Fish & Richardson PC:  “The office 
might be willing to grant patents ‘around the edges’ of marijuana, such as on a software 
system for managing marijuana crops, but I think it would have to be legal under federal law 
before the patent office is going to allow direct patents on marijuana strains”). 
199 See id. (quoting Robert Traver of Sheridan Ross PC, who pointed out the USPTO has 
issued patents on smoking paraphernalia that specifically state that the invention is designed 
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these results indicate plant patents and utility patents with claims directed 
to the plant “face [the] tough[est] road at the USPTO.”200  However, 
illegality should not be considered when determining patentable utility, 
and thus, all marijuana strains and marijuana-related inventions should 
not lack patentable utility under Whistler because marijuana is illegal 
under federal law.201 
D. A Solution for the Future 
Under Fuller and Whistler, plant patents and utility patents with 
claims directed to the plant are most likely not patentable for lack of legal 
utility.202  However, the patentability of marijuana strains and marijuana-
related inventions under Fuller and Whistler only reflects the reasoning of 
one lower court and an appeals court on an issue that is yet to be directly 
addressed by the USPTO, the Federal Circuit, or the Supreme Court.  
Specifically, no determination has been made on whether the illegality of 
an invention or its application affects a determination of patentable utility 
under the “specific and substantial benefit to the public” utility test set 
forth in Brenner.203  Therefore, the USPTO could assert marijuana-related 
inventions lack patentable utility because the illegal invention is incapable 
of providing any benefit to the public.204  Nevertheless, marijuana-related 
inventions should not lack patentable utility simply because the invention 
is illegal or has illegal applications.  First, Part III.D.1 recommends, if and 
when a court hears this issue, it should hold that an invention does not 
lack patentable utility if its subject matter is illegal or if the invention can 
be used for illegal purposes.205  Next, Part III.D.2 provides commentary on 
the holding. 
                                                
to be used for smoking marijuana).  Erich Veitenheimer of Cooley LLP also noted that the 
USPTO has issued patents for chemicals isolated from marijuana plants.  Id. 
200 See id. (exploring why “marijuana patent applications face though road at [the] 
USPTO”). 
201 See supra Part III.D (recommending courts hold that considering legality when 
determining patentable utility would be inconsistent with the goals of the patent system); 
1988 WL 212501, at *1 (indicating that a Congress ban on the subject matter of an invention 
would prevent the invention from having the requisite patentable utility). 
202 See supra Part III.C (applying Fuller and Whistler to marijuana-related inventions to 
determine whether the inventions would be patentable despite marijuana’s status as an 
illegal substance under federal law). 
203 See supra note 85 and accompanying text (stating that no court has determined whether 
an invention provides a specific and substantial benefit to the public despite its illegal status). 
204 See Davis, supra note 8 (noting that a rejection by the USPTO of a plant patent claiming 
a marijuana strain could expressly cite the classification of the drug as illegal or just reject it 
for claiming patent-ineligible subject matter). 
205 See infra Part III.D.1 (proposing that a court deciding on the patentability of marijuana 
inventions should hold that an invention, including marijuana-related inventions, does not 
lack patentable utility simply because the invention’s subject matter is illegal or can be used 
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1. Rejections for Lack of Legal Utility Are Inconsistent with the Goals of 
the Patent System 
Neither courts nor the USPTO have decided whether an invention 
lacks patentable utility under the “specific and substantial benefit to the 
public” utility test set forth in Brenner if the invention is useful for illegal 
purposes.206  This issue, however, will likely reach the courts in the 
upcoming years due to the influx of patent applications claiming 
marijuana strains and marijuana-related inventions.  While dicta in Fuller 
and Whistler could provide the legal basis for the USPTO to deny patents 
for lack of legal utility, a court hearing the issue should rule that 
considering legality when determining patentable utility is inconsistent 
with the goals of the patent system and the rights afforded by a patent.  
Thus, the USPTO should not deny marijuana-related patent applications 
for lack of utility simply based on marijuana’s classification as an illegal 
substance under federal law. 
2. Commentary 
First, granting a monopoly on an invention whose subject matter is 
illegal or that can be used for illegal purposes is not inconsistent with the 
rights granted by a patent.  A patent grants negative rights, and therefore, 
only affords the patentee the right to exclude others from using the 
invention.207  A patent, however, does not afford the patentee the exclusive 
right to use the invention.  The right to use the invention is a natural right 
of the inventor and is independent of the legal right to exclude others 
afforded by the patent.208  Consequently, a patent claiming subject matter 
                                                
for illegal purposes).  This Note proposes a model judicial holding and reasoning instead of 
a statutory amendment for two reasons.  First, patent law is rarely amended, and therefore, 
a proposed statutory amendment would be inappropriate.  See MUELLER, supra note 46, at 
33. (explaining the Patent Act of 1952 in amended form governs patent law today and that 
only two main revisions have taken place since its enactment:  The Patent Act of 1870 and 
the Leahy-Smith America Invents Act (“AIA”) in 2011).  Second, utility doctrine principles 
arise almost exclusively from case law, and thus, the patentability of marijuana is most likely 
to happen via court rulings.  MUELLER, supra note 46, at 33. 
206 See infra Part III.D.2 (highlighting the benefits and issues with a court holding that 
inventions do not lack patentable utility merely because the invention’s subject matter is 
illegal or because the invention is useful for illegal purposes). 
207 See MUELLER, supra note 46, at 15 (stating that patents grant negative rights and 
explaining the negative right to exclude granted by patents). 
208 See Fuller v. Berger, 120 F. 274, 279 (7th Cir. 1903) (“[S]tate law operates wholly upon 
the inventor’s natural right to the use of his property, and not at all upon the franchise which 
the patent grants, which consists altogether in the right to exclude.”).  Accordingly, in 
circumstances where practicing the patent or simply possessing the invention could be 
illegal, the patentee has the natural right to practice the invention, but he does not have the 
legal right to do so without possibly facing consequences.  See id. (explaining that laws 
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that is illegal or could be used for illegal purposes would grant the 
patentee the right to keep others from engaging in illegal activity, but it 
would not grant the patentee the right to engage in illegal activity by 
practicing his invention.  While the natural right to use the invention is 
affected by laws prohibiting the subject matter or use of the invention, the 
legal right to exclude others should not be affected.209  For example, if the 
USPTO granted patents on marijuana strains, it would not be allowing 
patentees to exclusively engage in illegal activity.  It would, however, 
encourage and allow the patentee to police illegal activity by affording 
him the right to exclude others from engaging in such illegal activity as a 
result of using the invention and infringing the patent.210 
One could argue, however, that even if granting patents does not 
allow patentees to engage in illegal activity, it encourages and enables 
others to engage in illegal activity.  A patent should disclose an invention 
well enough to enable others to practice the invention therein once the 
patent expires.  Accordingly, patents covering illegal inventions would 
allow people to engage in criminal practices unknown to them before the 
invention was patented.  It seems unlikely, however, that criminals would 
resort to the patent system to select their criminal practices.  But, if they 
did, they would open themselves to an infringement suit.  In addition, this 
is not a problem limited to patents covering illegal inventions.  
Theoretically, every time a patent is published, whether the invention is 
illegal or not, competitors are free to copy and practice the inventions 
disclosed therein.  The only thing keeping them from doing so is the 
possibility of an infringement suit.  In the case of criminals benefiting from 
patents covering illegal inventions, they would not only open themselves 
to an infringement lawsuit, but also to prosecution for engaging in 
criminal activity.  Hence, this argument relates to patent enforcement and 
not to the patentability of inventions. 
                                                
prohibiting the use of the invention only affect the patentees right to use the invention, not 
his right to exclude).  That, however, is collateral and irrelevant to his right under patent law 
to exclude others from using his invention.  Id. 
209 See id. (“His right to use his property is destroyed, but his right to exclude others stands 
unimpaired.”). 
210 See 35 U.S.C. § 154 (2012) (providing that patents grant “the right to exclude others from 
making, using, offering for sale, or selling the invention . . . .”).  Accordingly, it could also be 
argued that granting monopolies on illegal inventions would be beneficial to the 
government, since enforcement of the patent would result in private enforcement of the law, 
helping the police prosecute illegal activity.  For example, if Ben Holmes were to obtain a 
patent on his Otto II strain, he could sue for infringement whomever asexually reproduces 
the progeny of his strain.  MUELLER, supra note 46, at 288.  If the infringer is located in a state 
were marijuana remains illegal, Holmes, if successful in his infringement suit, would be 
preventing the infringer from engaging in illegal activity.  This could facilitate the DEA’s job. 
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Similarly, if the USPTO were to deny patent applications on the basis 
that they involve illegal subject matter or they would lead to illegal 
activity, the USPTO would be engaging in policing powers, which 
Congress did not afford.211  The utility requirement “is not a directive to 
the USPTO or the courts to serve as arbiters” of what is illegal and what is 
not, and what inventions people should use and which they should not.212  
Other agencies, such as the Federal Drug Administration, the Federal 
Trade Commission, and the DEA, are in charge of protecting consumers 
from dangerous food or drugs, deceptive products, and the prosecution 
for the use of illegal substances.  In addition, it would be extremely 
burdensome for the USPTO to have to engage in legality determinations, 
especially in the case of inventions, like marijuana, which might be legal 
in some states while illegal in others.  Accordingly, it is up to Congress to 
make an explicit determination that illegal subject matter, and inventions 
useful for illegal purposes, are not patentable.213  Until Congress does so, 
courts should maintain that illegal inventions are patentable provided 
they satisfy the other patentability requirements. 
                                                
211 See Juicy Whip, Inc. v. Orange Bang, 185 F.3d 1364, 1368 (Fed. Cir. 1999) (“Congress 
never intended that the patent laws should displace the policing powers of the States, 
meaning by that term those powers by which the health good order, peace and general 
welfare of the community are promoted.”).  It is not the responsibility of the USPTO to 
control social behavior by keeping illegal inventions from being patentable.  Id.  Such is the 
responsibility of the states by creating and enforcing laws.  Id.  Further, the USPTO is not in 
charge of protecting users from illegal or harmful inventions.  Id.  That is the job of other 
agencies such as the Federal Trade Commission, the Food and Drug Administration, the 
police force, or in the case of marijuana, the DEA.  Id. 
212 See id. (holding a deceptive device had patentable utility and indicating the utility 
requirement “is not a directive to the Patent and Trademark Office, or the courts to serve as 
arbiters of deceptive practices”). 
213 See Juicy Whip, Inc., 185 F.3d at 1368 (“Congress is free to declare particular types of 
inventions unpatentable for a variety of reasons . . . .”); Whistler Corp. v. Autotronics, Inc., 
No. CA3–85–2573–D, 1988 WL 212501, at *1 (N.D. Tex. July 28, 1988) (“Unless and 
until . . . Congress acts to withdraw patent protection for them, radar detector patentees are 
entitled to the protection of the patent laws.”).  In further support of this argument is the fact 
that Congress has already expressly withdrawn patent protection from inventions relating 
to atomic weapons.  See 42 U.S.C. § 2181(a) (2012) (“No patent shall hereafter be granted for 
any invention or discovery which is useful solely in the utilization of special nuclear material 
or atomic energy in an atomic weapon.”).  Such an action by Congress demonstrates that 
patent laws should be given a wide scope, unless Congress makes a determination to the 
contrary.  See Diamond v. Chakrabarty, 447 U.S. 303, 308 (1980) (“Congress contemplated 
that the patent laws would be given wide scope . . . .”).  In addition, courts and the USPTO 
“should not read into the patent laws limitations and conditions which the legislature has 
not expressed.”  United States v. Dubilier Condenser Corp., 289 U.S. 178, 199 (1933).  Thus, 
it would be incorrect for the USPTO to consider legality in determining patentable utility 
because no such limitation has been provided by the legislature. 
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Further, the patent system is in place to encourage dissemination of 
information and promote innovation.214  If illegal inventions are not 
patentable, secrecy would be encouraged and secrecy does not promote 
progress.215  One might argue that illegal inventions are a detriment to 
society.  Yet, an invention does not lack beneficial uses simply because it 
is illegal.  Marijuana is a perfect example since it has been shown that 
marijuana has medical benefits—just not benefits recognized by the 
federal government.216 
Another might argue that Congress could not have intended to 
encourage innovation in illegal fields.  However, laws and morals change 
with time, and laws are constantly subject to review and amendment.  So, 
while Congress might be concerned with the use of illegal inventions, it 
also understands that it is in society’s best interest to encourage disclosure 
and innovation in all fields since today marijuana might be illegal, but in 
the future it might not.217  Thus, marijuana inventors should not be denied 
                                                
214 See Brenner v. Manson, 383 U.S. 519, 532–33 (1966) (“[O]ne of the purposes of the patent 
system is to encourage dissemination of information concerning discoveries and 
inventions.”). 
215 See id. (“[I]nability to patent a process to some extent discourages disclosure and leads 
to greater secrecy than would otherwise be the case.”); In re Nelson, 280 F.2d 172, 181 
(C.C.P.A. 1960) (inhibiting dissemination retards progress).  Thus, if illegal inventions are 
patentable, the government will be kept on notice of how technology evolves.  Such notice, 
specifically in areas where it can exercise policing powers, is in the government’s best 
interest. 
216 See NIDA Research on the Therapeutic Benefits of Cannabis and Cannabinoids, NAT’L INST. 
ON DRUG ABUSE (May 2015), http://www.drugabuse.gov/drugs-abuse/marijuana/nida-
research-therapeutic-benefits-cannabis-cannabinoids [https://perma.cc/8NNC-W8FP] 
(listing the results of studies funded by twenty-eight grants and National Institute on Drug 
Abuse (“NIDA”) revealing the therapeutic advantages of marijuana). Like Joseph D. 
Summer explained: 
Assuming cannabis varieties serve a utilitarian purpose—and medical 
evidence suggest they do—providing patents for cannabis varieties 
promotes innovation in an industry ripe with opportunity. Cannabis 
cultivators will likely develop the best strains in the hopes of achieving 
legal legitimacy and protection from the federal government. The 
possibilities for invention and innovation are limitless.  Preclusion of 
cannabis variety patents would likely result in a chilling effect on the 
cannabis industry as a whole . . . . [A]ssuming cannabis does have a 
medical use, innovation in cannabis varieties may catalyze the 
development of unimagined pharmaceutical drugs and spur entirely 
new industries. 
Joseph D. Summer, Patenting Marijuana Strains: Baking up Patent Protection for Growers in the 
Legal Fog of This Budding Industry, 23 J. INTELL. PROP. L. 169, 206 (2015) (internal citations 
omitted). 
217 See In re Nelson, 280 F.2d at 181 (“Refusal to protect them at this stage would inhibit 
their wide dissemination, together with the knowledge of them which a patent disclosure 
conveys, which disclosure the potential protection encourages.  This would tend to retard 
rather than promote progress.”). 
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the protections of patent law simply because the inventions cannot be 
currently used.  Specifically, patent law is not concerned with the use of 
an invention, but with the progress fostered by the development of new 
technologies.  For example, if marijuana inventions were patentable, 
inventors would be put on notice of where research and progress in the 
field stands, allowing inventors to engage in innovation and research that 
produces better and safer technologies.218  Dissemination of information 
through patents would offer a better understanding of marijuana and 
could potentially lead to discoveries that warrant legalizing marijuana at 
the federal level. 
However, one could further argue that even if marijuana plants and 
marijuana-related inventions were patentable, the patents covering such 
inventions would not be enforceable and therefore useless patents.219  This 
argument is premised on the fact that courts do not enforce illegal 
rights.220  First, assuming the patents would not be initially enforceable, 
this argument further highlights the importance of allowing patent 
protection for marijuana patents as soon as possible.  While the patent 
might not be initially enforceable, if marijuana laws were to change within 
the next twenty years, which would be the term of these patents if granted, 
the patentee would have the ability to sue the infringer once the laws 
changed.  If the patents were not granted and marijuana later becomes 
legal, the patentee will have altogether lost any right to profit from his 
invention via the patent system.  Second, this argument is only applicable 
to those cases in which the patentee is also practicing the invention.  Since, 
                                                
218 For example, if an inventor discovers that a medication with high levels of CBD, but 
low levels of THC is useful in treating epilepsy and is granted a patent on such method of 
treatment, other inventors will know that such application has been discovered.  Thus, they 
would be steered towards researching other applications of the ratio or even other ratios to 
treat a different illness.  But, if the first inventor was not allowed to patent his method, all 
inventors could potentially be wasting money in researching the same method of treatment 
while their time could be better spent researching and creating a variety of methods of 
treatment. 
219 See Ciccatelli, supra note 7 (interviewing Douglas J. Sorocco, the director and 
shareholder of Dunlap Codding, who “cannot imagine that a federal patent infringement 
action on marijuana wouldn’t attract heightened scrutiny to the activities of the alleged 
infringer as well as the patent holder.”); Forest, Cannabis IP Remedies:  Erie-ly Familiar, Patently 
Different, DRUG L. & POL’Y (Apr. 16, 2015), https://druglawandpolicy.wordpress.com/ 
2015/04/16/cannabis-ip-remedies-erie-ly-familiar-patently-different/ [https://perma.cc/ 
62TB-VAD6] (discussing whether marijuana-related intellectual property rights would be 
enforceable); Milton Springut, High on IP:  Marijuana-Related Intellectual Property Law, N.Y. 
L.J. (Jan. 12, 2015), http://www.newyorklawjournal.com/id=1202714579594/High-on-IP-
MarijuanaRelated-Intellectual-Property-Law [https://perma.cc/D547-2FD8] (noting it is 
unclear whether a court would enforce marijuana-related patents). 
220 See Springut, supra note 219 (explaining that in both contract and tort law, plaintiffs are 
unable to pursue legal remedies arising in connection with their own illegal act). 
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a patent does not grant the patentee the exclusive right to practice the 
patent, it does not necessarily follow that a patentee that seeks to exclude 
another from using his invention is himself also using the invention.  For 
example, if a marijuana plant patent holder seeks to exclude another from 
asexually reproducing his strain, it does not follow that the patentee has 
been himself reproducing the strain.  Thus, patentees seeking to enforce 
their rights under the patent, and who have not been practicing the patent, 
should have no issues.  Lastly, this is an argument of enforceability that 
should not bear on the patentability of inventions. 
Finally, the Patent Act is silent on morality and illegality, while the 
Lanham Act, the statute governing trademark law, contains a morality 
clause.221  Congress passed the Lanham Act in 1946, almost ten years 
before the Patent Act.222  If Congress intended to limit the patentability of 
illegal or immoral subject matter, like it intended to limit the grant of 
trademarks on scandalous or immoral marks, it would have included a 
morality or legality clause in the Patent Act.  Thus, the absence of a 
morality or legality clause in the Patent Act further supports the 
conclusion that illegal subject matter is patentable. 
IV.  CONCLUSION 
As states legalize medical and recreational marijuana and the industry 
continues to grow, entrepreneurs are becoming increasingly interested in 
protecting their inventions under patent law.  However, patent rights are 
established under federal law and marijuana remains illegal federally.  
Consequently, attorneys argue it is unlikely that the USPTO will issue 
patents protecting marijuana-related inventions.  Specifically, courts have 
never determined whether illegality affects the patentable utility of an 
invention.  In the past, courts invalidated patents if they lacked moral 
utility under the moral utility doctrine.  However, this doctrine is no 
longer good law.  Nonetheless, some of the cases discussing the moral 
utility doctrine suggest that an invention would be unpatentable if 
Congress banned the subject matter of the invention.  Thus, it appears 
marijuana strains and some marijuana-related inventions would not be 
patentable. 
                                                
221 See 15 U.S.C. § 1052(a) (2012) (“No trademark by which the goods of the applicant may 
be distinguished from the goods of others shall be refused registration on the principal 
register on account of its nature unless it—(a) Consists of or comprises immoral, deceptive, 
or scandalous matter . . . .”). 
222 See Lanham Act, CORNELL U. L. SCH. LEGAL INFO. INST. (Oct. 30, 2015), 
https://www.law.cornell.edu/wex/lanham_act [https://perma.cc/A4FR-4UZB] 
(indicating Congress passed the Lanham Act in 1946 based on the power granted to it by the 
Commerce Clause of the Constitution). 
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Nonetheless, the USPTO should not deny marijuana-related patent 
applications based solely on the fact that marijuana is illegal under federal 
law.  Accordingly, Ben Holmes’s patent application on his Otto II medical-
grade marijuana strain should be granted provided it satisfies all the 
requirements necessary to obtain a plant patent.  Specifically, illegality 
should not play a role in determining whether an invention is patentable 
or not.  Considering legality in a determination of patentability would be 
inconsistent with the goals of the patent system of promoting disclosure 
and innovation.  Further, there is no detriment to the public from allowing 
the patentability of illegal inventions because patent rights are negative 
rights.  Last, it is up to Congress to make an explicit determination that 
illegal subject matter is not patentable; this is not for the USPTO nor the 
courts to decide.  Unless, and until, Congress determines illegality should 
play a role in determining patentable utility, courts should hold that illegal 
inventions cannot be denied for lack of patentable utility.  Therefore, 
marijuana-related inventions do not lack patentable utility based on 
marijuana’s illegal status under federal law. 
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